👪

Inheritance

2

Autosomal dominant HP:0000006

Many reported PLCB4 and GNAI3 families show autosomal dominant inheritance, often with variable expressivity and incomplete penetrance.

Autosomal dominant inheritance Expressivity: VARIABLE

Show evidence (2 references)

PMID:28328130 SUPPORT Human Clinical

"Auriculocondylar syndrome, mainly characterized by micrognathia, small mandibular condyle, and question mark ears, is a rare disease segregating in an autosomal dominant pattern in the majority of the families reported in the literature."

This cohort review directly supports autosomal dominant inheritance as the most common reported pattern.

PMID:38618928 SUPPORT Human Clinical

"As with other studies examining familial cases of ARCND2, incomplete penetrance and variable expressivity were observed within different families' heterozygous mutations in PLCB4 gene."

The 2024 review supports variable expressivity and incomplete penetrance in PLCB4-related families.

Autosomal recessive HP:0000007

Recessive auriculocondylar syndrome has been reported for EDN1 variants and for biallelic PLCB4 loss-of-function lesions.

Autosomal recessive inheritance

Show evidence (2 references)

PMID:24268655 SUPPORT Human Clinical

"By whole-exome sequencing (WES), we identified a homozygous substitution in a furin cleavage site of the EDN1 proprotein in ACS-affected siblings born to consanguineous parents."

This directly supports recessive EDN1-related auriculocondylar syndrome.

PMID:23315542 SUPPORT Human Clinical

"CONCLUSIONS: These findings indicate that ACS is not only genetically heterogeneous but also an autosomal dominant or recessive condition according to the nature of the PLCB4 gene lesion."

This directly supports recessive inheritance for some PLCB4 lesions.

◆

Subtypes

5

ARCND1 (GNAI3-related)

Usually autosomal dominant auriculocondylar syndrome caused by heterozygous GNAI3 variants affecting GDP/GTP-binding motifs and EDN1 pathway signaling.

Show evidence (1 reference)

PMID:38618928 SUPPORT Human Clinical

"Four subtypes of ARCND have been described so far, that is, ARCND1 (OMIM # 602483), ARCND2 (ARCND2A, OMIM # 614669; ARCND2B, OMIM # 620458), ARCND3 (OMIM # 615706), and ARCND4 (OMIM # 620457)."

This identifies ARCND1 and its OMIM identifier.

ARCND2A (PLCB4-related, autosomal dominant)

Autosomal dominant PLCB4-related auriculocondylar syndrome, typically caused by heterozygous missense variants.

Show evidence (1 reference)

PMID:38618928 SUPPORT Human Clinical

"Four subtypes of ARCND have been described so far, that is, ARCND1 (OMIM # 602483), ARCND2 (ARCND2A, OMIM # 614669; ARCND2B, OMIM # 620458), ARCND3 (OMIM # 615706), and ARCND4 (OMIM # 620457)."

This identifies ARCND2A and its OMIM identifier.

ARCND2B (PLCB4-related, autosomal recessive)

Autosomal recessive PLCB4-related auriculocondylar syndrome caused by biallelic loss-of-function or damaging PLCB4 variants.

Show evidence (1 reference)

PMID:38618928 SUPPORT Human Clinical

"Four subtypes of ARCND have been described so far, that is, ARCND1 (OMIM # 602483), ARCND2 (ARCND2A, OMIM # 614669; ARCND2B, OMIM # 620458), ARCND3 (OMIM # 615706), and ARCND4 (OMIM # 620457)."

This identifies ARCND2B and its OMIM identifier.

ARCND3 (EDN1-related)

EDN1-related disease includes recessive auriculocondylar syndrome and dominant isolated question mark ear, depending on the variant and residual endothelin 1 activity.

Show evidence (1 reference)

PMID:38618928 SUPPORT Human Clinical

"Four subtypes of ARCND have been described so far, that is, ARCND1 (OMIM # 602483), ARCND2 (ARCND2A, OMIM # 614669; ARCND2B, OMIM # 620458), ARCND3 (OMIM # 615706), and ARCND4 (OMIM # 620457)."

This identifies ARCND3 and its OMIM identifier.

ARCND4 (TWIST1 regulatory duplication)

A regulatory locus caused by a 430 kb duplication involving HDAC9 and TWIST1 regulatory elements, altering TWIST1 expression during craniofacial development.

Show evidence (1 reference)

PMID:38618928 SUPPORT Human Clinical

"Four subtypes of ARCND have been described so far, that is, ARCND1 (OMIM # 602483), ARCND2 (ARCND2A, OMIM # 614669; ARCND2B, OMIM # 620458), ARCND3 (OMIM # 615706), and ARCND4 (OMIM # 620457)."

This identifies ARCND4 and its OMIM identifier.

⚙

Pathophysiology

5

EDN1-EDNRA Craniofacial Signaling Disruption

The central mechanism is impaired endothelin 1 signaling during early pharyngeal arch patterning. EDN1 ligand, EDNRA receptor signaling, and downstream GNAI3 and PLCB4 effectors help specify mandibular identity in cranial neural crest-derived tissues; disruption reduces downstream DLX5/DLX6 expression and repatterns mandibular structures toward a more maxillary-like identity.

cranial neural crest cell link

EDN1 link GNAI3 link PLCB4 link

signal transduction link ↓ DECREASED

Downstream

Mandibular condyle hypoplasia Impaired mandibular identity specification disrupts condylar development.

Micrognathia Mandibular hypoplasia results from abnormal first arch-derived jaw patterning.

Question mark ear External ear malformation accompanies first and second arch patterning defects.

Show evidence (2 references)

PMID:22560091 SUPPORT In Vitro

"Functional studies demonstrated a significant reduction in downstream DLX5 and DLX6 expression in ACS cases in assays using cultured osteoblasts from probands and controls."

Patient-derived osteoblast assays directly support reduced DLX5/DLX6 output downstream of PLCB4 and GNAI3 mutations.

PMID:24268655 SUPPORT Human Clinical

"These findings provide further support for the hypothesis that ACS and QMEs are uniquely caused by disruption of the EDN1-EDNRA signaling pathway."

EDN1 mutation discovery supports EDN1-EDNRA pathway disruption as a unifying disease mechanism.

Cranial Neural Crest Patterning Defect

Cranial neural crest cells populate the pharyngeal arches and generate most craniofacial bone, cartilage, and connective tissue. In auriculocondylar syndrome, disturbed neural crest identity and patterning underlie ear and mandibular malformations.

cranial neural crest cell link

neural crest cell migration link ⚠ ABNORMAL

Downstream

EDN1-EDNRA Craniofacial Signaling Disruption Developmental patterning defects converge on the EDN1-DLX5/6 mandibular identity program.

Show evidence (2 references)

PMID:24123988 SUPPORT Other

"Affected structures arise from cranial neural crest cells, a population of cells in the embryo that reside in the pharyngeal arches and give rise to most of the bone, cartilage and connective tissue of the face."

This review links affected auriculocondylar structures to cranial neural crest-derived tissues.

PMID:24123988 SUPPORT Model Organism

"Disruption of this signaling pathway in both mouse and zebrafish results in loss of identity of neural crest cells of the mandibular portion of the first pharyngeal arch and the subsequent repatterning of these cells, leading to homeosis of lower jaw structures into more maxillary-like structures."

Mouse and zebrafish evidence supports neural crest mandibular identity loss as a mechanism for the craniofacial phenotype.

Dominant-Negative GNAI3 Dysfunction

GNAI3 variants cluster around GDP/GTP-binding motifs and are proposed to act through a dominant-negative mechanism that interferes with endothelin pathway signal transduction during pharyngeal arch development.

GNAI3 link

signal transduction link ↓ DECREASED

Downstream

EDN1-EDNRA Craniofacial Signaling Disruption GNAI3 acts as an intracellular effector in the EDN1-EDNRA developmental signaling pathway.

Show evidence (2 references)

PMID:25026904 SUPPORT Human Clinical

"Structural modeling shows that all five altered GNAI3 residues identified to date cluster in a region involved in GDP/GTP binding."

Variant clustering near GDP/GTP binding supports disrupted GNAI3 signaling function.

PMID:25026904 SUPPORT Human Clinical

"We hypothesize that all GNAI3 variants lead to dominant negative effects."

The abstract explicitly supports a dominant-negative interpretation for GNAI3 variants.

PLCB4 Catalytic Domain Dysfunction

PLCB4 variants include heterozygous missense variants clustered in protein domains and biallelic loss-of-function lesions. Heterozygous missense variants are proposed to interfere dominantly rather than act through simple haploinsufficiency.

PLCB4 link

signal transduction link ↓ DECREASED

Downstream

EDN1-EDNRA Craniofacial Signaling Disruption PLCB4 acts as an intracellular effector in the EDN1-EDNRA developmental signaling pathway.

Show evidence (2 references)

PMID:23315542 SUPPORT Human Clinical

"The narrow distribution of mutations within protein space suggests that the mutations may result in dominantly interfering proteins, rather than haploinsufficiency."

This supports a dominant-interference mechanism for many heterozygous PLCB4 missense variants.

PMID:38618928 SUPPORT Human Clinical

"Trio-based whole-exome sequencing identified a novel missense variant of NM_001377142.1:c.1928C>T (NP_001364071.1:p.Ser643Phe) in the PLCB4 gene, which was predicted to impair the local structural stability with a result that the protein function might be affected."

A recent neonatal case supports PLCB4 structural and functional disruption in ARCND2.

TWIST1 Regulatory Dosage Disruption

A 430 kb duplication involving HDAC9 and TWIST1 regulatory elements can deregulate TWIST1 expression in neural crest cells and impair neural crest migration and osteogenic differentiation.

neural crest cell link mesenchymal stem cell link

TWIST1 link

neural crest cell migration link ↓ DECREASED

Downstream

Cranial Neural Crest Patterning Defect TWIST1 regulatory dysregulation impairs neural crest migration and craniofacial differentiation programs.

Show evidence (2 references)

PMID:34750192 SUPPORT In Vitro

"We also identified decreased migration of iPSC-derived neural crest cells together with dysregulation of osteogenic differentiation in iPSC-affected mesenchymal stem cells."

Patient iPSC-derived cellular models directly support neural crest migration and osteogenic differentiation defects.

PMID:34750192 SUPPORT In Vitro

"Our findings support the hypothesis that the 430 kb duplication is causative of the ARCND phenotype in this family and that deregulation of TWIST1 expression during craniofacial development can contribute to the phenotype."

The study supports regulatory TWIST1 dosage disruption as an ARCND mechanism.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

10

Ear 1

Hearing impairment Hearing impairment (HP:0000365)

Show evidence (2 references)

PMID:22865651 SUPPORT Human Clinical

"We describe a 14-year-old male with constricted pinnae, mandibular dysostosis, glossoptosis, a high-arched palate, hearing loss, and cholesteatoma."

This case report directly documents hearing loss in auriculo-condylar syndrome.

PMID:22865651 SUPPORT Human Clinical

"Computed tomography imaging demonstrated malleoincudal joint ankylosis."

Middle-ear ossicular ankylosis supports a plausible structural basis for conductive hearing impairment.

Head and Neck 2

Micrognathia FREQUENT Micrognathia (HP:0000347)

Show evidence (2 references)

PMID:34789173 SUPPORT Human Clinical

"BACKGROUND: Auriculocondylar syndrome (ACS) is a rare disorder characterized by micrognathia, mandibular condyle hypoplasia, and auricular abnormalities."

Prenatal case report directly identifies micrognathia as a core disease characteristic.

PMID:34789173 SUPPORT Human Clinical

"Severe micrognathia and mandibular hypoplasia were identified on ultrasonography."

This supports prenatal detectability of severe micrognathia.

Cleft palate Cleft palate (HP:0000175)

Show evidence (1 reference)

PMID:22560091 SUPPORT Human Clinical

"Auriculocondylar syndrome (ACS) is a rare, autosomal-dominant craniofacial malformation syndrome characterized by variable micrognathia, temporomandibular joint ankylosis, cleft palate, and a characteristic "question-mark" ear malformation."

The original PLCB4/GNAI3 discovery paper includes cleft palate among variable clinical features.

Respiratory 1

Respiratory distress Respiratory distress (HP:0002098)

Show evidence (1 reference)

PMID:38618928 SUPPORT Human Clinical

"The proband, a 5-day-old male neonate, was referred to our hospital for respiratory distress."

A recent neonatal ARCND2 case directly documents respiratory distress.

Other 6

Question mark ear FREQUENT Question mark ear (HP:0030022)

Show evidence (2 references)

PMID:24268655 SUPPORT Human Clinical

"Auriculocondylar syndrome (ACS) is a rare craniofacial disorder with mandibular hypoplasia and question-mark ears (QMEs) as major features."

This directly supports question mark ears as a major feature.

PMID:38618928 SUPPORT Human Clinical

"Micrognathia, microstomia, distinctive question mark ears, as well as mandibular condyle hypoplasia were identified."

A recent PLCB4 neonatal case directly documents question mark ears.

Mandibular condyle hypoplasia FREQUENT Mandibular condyle hypoplasia (HP:0007628)

Show evidence (2 references)

PMID:39014351 SUPPORT Human Clinical

"BACKGROUND: Auriculocondylar syndrome (ARCND) is an extremely rare autosomal dominant or recessive condition that typically manifests as question mark ears (QMEs), mandibular condyle hypoplasia, and micrognathia."

This recent clinical report directly supports mandibular condyle hypoplasia as a typical manifestation.

PMID:28328130 SUPPORT Human Clinical

"Auriculocondylar syndrome, mainly characterized by micrognathia, small mandibular condyle, and question mark ears, is a rare disease segregating in an autosomal dominant pattern in the majority of the families reported in the literature."

This supports small mandibular condyle as a main disease feature.

Microstomia

Show evidence (1 reference)

PMID:38618928 SUPPORT Human Clinical

"Micrognathia, microstomia, distinctive question mark ears, as well as mandibular condyle hypoplasia were identified."

The cited neonatal case directly reports microstomia in PLCB4-related ARCND2.

Temporomandibular joint ankylosis Temporomandibular joint ankylosis (HP:0012478)

Show evidence (1 reference)

PMID:22560091 SUPPORT Human Clinical

"Auriculocondylar syndrome (ACS) is a rare, autosomal-dominant craniofacial malformation syndrome characterized by variable micrognathia, temporomandibular joint ankylosis, cleft palate, and a characteristic "question-mark" ear malformation."

This original discovery paper directly lists temporomandibular joint ankylosis as a clinical feature.

Polyhydramnios

Show evidence (1 reference)

PMID:34789173 SUPPORT Human Clinical

"Severe micrognathia and mandibular hypoplasia accompanied by polyhydramnios are prenatal indicators of ACS."

This directly supports polyhydramnios as a prenatal indicator when combined with severe mandibular findings.

Full cheeks Full cheeks (HP:0000293)

Show evidence (1 reference)

PMID:28328130 SUPPORT Human Clinical

"We also performed a detailed comparative analysis of the patients presented in this study with those previously published, which showed that the pattern of auricular abnormality and full cheeks were associated with molecularly characterized individuals with Auriculocondylar syndrome."

The molecular cohort analysis directly associates full cheeks with molecularly confirmed disease.

🧬

Genetic Associations

4

GNAI3 pathogenic variants (Causative)

Show evidence (2 references)

PMID:25026904 SUPPORT Human Clinical

"Causative variants have been identified in PLCB4, GNAI3 and EDN1, which are predicted to function within the EDN1-EDNRA pathway during early pharyngeal arch patterning."

This directly includes GNAI3 among causative genes in the pathway.

PMID:39014351 SUPPORT Human Clinical

"A novel insertional mutation in the guanine nucleotide-binding protein alpha-inhibiting activity polypeptide 3 (GNAI3) was identified in the patient and their brother using whole-exome sequencing."

A recent family report supports GNAI3 as a causal gene and illustrates WES diagnosis.

PLCB4 pathogenic variants (Causative)

Show evidence (2 references)

PMID:28328130 SUPPORT Human Clinical

"So far, pathogenic variants in PLCB4, GNAI3, and EDN1 have been associated with this syndrome."

This cohort paper directly supports PLCB4 as an associated causative gene.

PMID:38618928 SUPPORT Human Clinical

"METHODS: This study reports a case of ARCND2 resulting from a novel pathogenic variant in the PLCB4 gene, and summarizes PLCB4 gene mutation sites and phenotypes of ARCND2."

Recent case report directly supports PLCB4 variants as causative for ARCND2.

EDN1 pathogenic variants (Causative)

Show evidence (1 reference)

PMID:24268655 SUPPORT Human Clinical

"Targeted sequencing of EDN1 in an ACS individual with related parents identified a fourth, homozygous mutation falling close to the site of cleavage by endothelin-converting enzyme."

This supports EDN1 as a causal gene for recessive auriculocondylar syndrome.

TWIST1 regulatory duplication (Causative)

Show evidence (1 reference)

PMID:34750192 SUPPORT Human Clinical

"This study highlights a fourth locus causative of ARCND, represented by a tandem duplication of 430 kb in a candidate region on chromosome 7 defined by linkage analysis."

This directly supports the structural regulatory duplication as a causative ARCND locus.

💊

Treatments

4

Multidisciplinary Craniofacial Surgery

Action: surgical procedure MAXO:0000004

Severe dentofacial deformities may be treated with staged craniofacial surgery, including distraction osteogenesis and orthognathic surgery, often guided by three-dimensional digital planning.

Target Phenotypes: Micrognathia ↗ Mandibular condyle hypoplasia ↗

Show evidence (2 references)

PMID:39014351 SUPPORT Human Clinical

"After a multidisciplinary consultation and examination, sequential orthodontic treatment and craniofacial surgery, including distraction osteogenesis and orthognathic surgery, were performed using three-dimensional (3D) digital technology to treat the patient's dentofacial deformity."

This directly supports multidisciplinary staged craniofacial surgical management.

PMID:39014351 SUPPORT Human Clinical

"Sequential therapy with preoperative orthodontic treatment combined with distraction osteogenesis and orthognathic surgery guided by 3D digital technology may be a practical and effective method for treating ARCND."

The conclusion supports this approach as a practical treatment option for severe ARCND dentofacial deformity.

Distraction Osteogenesis

Action: distraction osteogenesis MAXO:0000486

Mandibular distraction osteogenesis can be part of staged treatment for severe mandibular and airway-related dentofacial deformity.

Target Phenotypes: Micrognathia ↗

Show evidence (1 reference)

PMID:39014351 SUPPORT Human Clinical

"Sequential therapy with preoperative orthodontic treatment combined with distraction osteogenesis and orthognathic surgery guided by 3D digital technology may be a practical and effective method for treating ARCND."

This directly names distraction osteogenesis as part of effective staged treatment.

Supportive Airway and Feeding Care

Action: supportive care MAXO:0000950

Infants with severe mandibular hypoplasia, microstomia, or respiratory distress require individualized supportive airway, feeding, dental, and craniofacial specialty care.

Target Phenotypes: Respiratory distress ↗

Show evidence (1 reference)

PMID:38618928 SUPPORT Human Clinical

"The proband, a 5-day-old male neonate, was referred to our hospital for respiratory distress."

This supports the need to monitor and manage airway complications in severe neonatal presentations.

Genetic Counseling

Action: genetic counseling MAXO:0000079

Genetic counseling should address autosomal dominant and recessive inheritance, incomplete penetrance, variable expressivity, recurrence risk, and options for prenatal or family testing when a pathogenic variant is known.

Show evidence (1 reference)

PMID:34789173 SUPPORT Human Clinical

"A woman with 30 weeks of gestation was referred to genetic counseling for polyhydramnios and fetal craniofacial anomaly."

This prenatal case supports the relevance of genetic counseling when fetal craniofacial anomalies suggest ACS.

🔀

Differential Diagnoses

1

Conditions with similar clinical presentations that must be differentiated from Auriculocondylar Syndrome:

Pierre Robin sequence-plus

Overlapping Features Pierre Robin sequence and Pierre Robin sequence-plus overlap through micrognathia and clefting, but question mark ears and mandibular condyle hypoplasia point toward auriculocondylar syndrome.

Distinguishing Features

Question mark ears
Mandibular condyle hypoplasia

Show evidence (1 reference)

PMID:28328130 SUPPORT Human Clinical

"In order to address these questions, we searched for alterations in PLCB4, GNAI3, and EDN1 in patients with typical Auriculocondylar syndrome (n = 3), Pierre Robin sequence-plus (n = 3), micrognathia with additional craniofacial malformations (n = 4), or non-specific auricular dysplasia (n = 1),..."

This supports Pierre Robin sequence-plus as part of the clinical differential or spectrum considered in testing.

{ }

Source YAML

click to show

name: Auriculocondylar Syndrome
creation_date: "2026-05-10T15:02:55Z"
updated_date: "2026-05-10T15:45:00Z"
description: >-
  Auriculocondylar syndrome is an ultra-rare congenital craniofacial
  malformation syndrome affecting first and second pharyngeal arch derivatives.
  It is characterized by question mark ears, mandibular condyle hypoplasia,
  micrognathia, and variable oral, airway, and developmental complications.
  Most known causes disrupt the EDN1-EDNRA developmental signaling axis or
  cranial neural crest regulatory programs.
category: Mendelian
parents:
- ear malformation
- craniofacial malformation syndrome
synonyms:
- auriculo-condylar syndrome
- question mark ear syndrome
- dysgnathia complex
disease_term:
  preferred_term: auriculocondylar syndrome
  term:
    id: MONDO:0000107
    label: auriculocondylar syndrome
has_subtypes:
- name: ARCND1
  display_name: ARCND1 (GNAI3-related)
  subtype_term:
    preferred_term: ARCND1 (OMIM:602483)
  description: >-
    Usually autosomal dominant auriculocondylar syndrome caused by heterozygous
    GNAI3 variants affecting GDP/GTP-binding motifs and EDN1 pathway signaling.
  evidence:
  - reference: PMID:38618928
    reference_title: "Auriculocondylar syndrome 2 caused by a novel PLCB4 variant in a male Chinese neonate: A case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Four subtypes of ARCND have been described so far, that is, ARCND1 (OMIM # 602483), ARCND2 (ARCND2A, OMIM # 614669; ARCND2B, OMIM # 620458), ARCND3 (OMIM # 615706), and ARCND4 (OMIM # 620457)."
    explanation: This identifies ARCND1 and its OMIM identifier.
- name: ARCND2A
  display_name: ARCND2A (PLCB4-related, autosomal dominant)
  subtype_term:
    preferred_term: ARCND2A (OMIM:614669)
  description: >-
    Autosomal dominant PLCB4-related auriculocondylar syndrome, typically caused
    by heterozygous missense variants.
  evidence:
  - reference: PMID:38618928
    reference_title: "Auriculocondylar syndrome 2 caused by a novel PLCB4 variant in a male Chinese neonate: A case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Four subtypes of ARCND have been described so far, that is, ARCND1 (OMIM # 602483), ARCND2 (ARCND2A, OMIM # 614669; ARCND2B, OMIM # 620458), ARCND3 (OMIM # 615706), and ARCND4 (OMIM # 620457)."
    explanation: This identifies ARCND2A and its OMIM identifier.
- name: ARCND2B
  display_name: ARCND2B (PLCB4-related, autosomal recessive)
  subtype_term:
    preferred_term: ARCND2B (OMIM:620458)
  description: >-
    Autosomal recessive PLCB4-related auriculocondylar syndrome caused by
    biallelic loss-of-function or damaging PLCB4 variants.
  evidence:
  - reference: PMID:38618928
    reference_title: "Auriculocondylar syndrome 2 caused by a novel PLCB4 variant in a male Chinese neonate: A case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Four subtypes of ARCND have been described so far, that is, ARCND1 (OMIM # 602483), ARCND2 (ARCND2A, OMIM # 614669; ARCND2B, OMIM # 620458), ARCND3 (OMIM # 615706), and ARCND4 (OMIM # 620457)."
    explanation: This identifies ARCND2B and its OMIM identifier.
- name: ARCND3
  display_name: ARCND3 (EDN1-related)
  subtype_term:
    preferred_term: ARCND3 (OMIM:615706)
  description: >-
    EDN1-related disease includes recessive auriculocondylar syndrome and
    dominant isolated question mark ear, depending on the variant and residual
    endothelin 1 activity.
  evidence:
  - reference: PMID:38618928
    reference_title: "Auriculocondylar syndrome 2 caused by a novel PLCB4 variant in a male Chinese neonate: A case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Four subtypes of ARCND have been described so far, that is, ARCND1 (OMIM # 602483), ARCND2 (ARCND2A, OMIM # 614669; ARCND2B, OMIM # 620458), ARCND3 (OMIM # 615706), and ARCND4 (OMIM # 620457)."
    explanation: This identifies ARCND3 and its OMIM identifier.
- name: ARCND4
  display_name: ARCND4 (TWIST1 regulatory duplication)
  subtype_term:
    preferred_term: ARCND4 (OMIM:620457)
  description: >-
    A regulatory locus caused by a 430 kb duplication involving HDAC9 and
    TWIST1 regulatory elements, altering TWIST1 expression during craniofacial
    development.
  evidence:
  - reference: PMID:38618928
    reference_title: "Auriculocondylar syndrome 2 caused by a novel PLCB4 variant in a male Chinese neonate: A case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Four subtypes of ARCND have been described so far, that is, ARCND1 (OMIM # 602483), ARCND2 (ARCND2A, OMIM # 614669; ARCND2B, OMIM # 620458), ARCND3 (OMIM # 615706), and ARCND4 (OMIM # 620457)."
    explanation: This identifies ARCND4 and its OMIM identifier.
inheritance:
- name: Autosomal dominant
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  expressivity: VARIABLE
  description: >-
    Many reported PLCB4 and GNAI3 families show autosomal dominant inheritance,
    often with variable expressivity and incomplete penetrance.
  evidence:
  - reference: PMID:28328130
    reference_title: "Targeted molecular investigation in patients within the clinical spectrum of Auriculocondylar syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Auriculocondylar syndrome, mainly characterized by micrognathia, small mandibular condyle, and question mark ears, is a rare disease segregating in an autosomal dominant pattern in the majority of the families reported in the literature."
    explanation: This cohort review directly supports autosomal dominant inheritance as the most common reported pattern.
  - reference: PMID:38618928
    reference_title: "Auriculocondylar syndrome 2 caused by a novel PLCB4 variant in a male Chinese neonate: A case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "As with other studies examining familial cases of ARCND2, incomplete penetrance and variable expressivity were observed within different families' heterozygous mutations in PLCB4 gene."
    explanation: The 2024 review supports variable expressivity and incomplete penetrance in PLCB4-related families.
- name: Autosomal recessive
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  description: >-
    Recessive auriculocondylar syndrome has been reported for EDN1 variants and
    for biallelic PLCB4 loss-of-function lesions.
  evidence:
  - reference: PMID:24268655
    reference_title: "Mutations in endothelin 1 cause recessive auriculocondylar syndrome and dominant isolated question-mark ears."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "By whole-exome sequencing (WES), we identified a homozygous substitution in a furin cleavage site of the EDN1 proprotein in ACS-affected siblings born to consanguineous parents."
    explanation: This directly supports recessive EDN1-related auriculocondylar syndrome.
  - reference: PMID:23315542
    reference_title: "Heterogeneity of mutational mechanisms and modes of inheritance in auriculocondylar syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "CONCLUSIONS: These findings indicate that ACS is not only genetically heterogeneous but also an autosomal dominant or recessive condition according to the nature of the PLCB4 gene lesion."
    explanation: This directly supports recessive inheritance for some PLCB4 lesions.
pathophysiology:
- name: EDN1-EDNRA Craniofacial Signaling Disruption
  description: >-
    The central mechanism is impaired endothelin 1 signaling during early
    pharyngeal arch patterning. EDN1 ligand, EDNRA receptor signaling, and
    downstream GNAI3 and PLCB4 effectors help specify mandibular identity in
    cranial neural crest-derived tissues; disruption reduces downstream
    DLX5/DLX6 expression and repatterns mandibular structures toward a more
    maxillary-like identity.
  genes:
  - preferred_term: EDN1
    term:
      id: hgnc:3176
      label: EDN1
  - preferred_term: GNAI3
    term:
      id: hgnc:4387
      label: GNAI3
  - preferred_term: PLCB4
    term:
      id: hgnc:9059
      label: PLCB4
  cell_types:
  - preferred_term: cranial neural crest cell
    term:
      id: CL:0000008
      label: migratory cranial neural crest cell
  biological_processes:
  - preferred_term: signal transduction
    term:
      id: GO:0007165
      label: signal transduction
    modifier: DECREASED
  evidence:
  - reference: PMID:22560091
    reference_title: "A human homeotic transformation resulting from mutations in PLCB4 and GNAI3 causes auriculocondylar syndrome."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Functional studies demonstrated a significant reduction in downstream DLX5 and DLX6 expression in ACS cases in assays using cultured osteoblasts from probands and controls."
    explanation: Patient-derived osteoblast assays directly support reduced DLX5/DLX6 output downstream of PLCB4 and GNAI3 mutations.
  - reference: PMID:24268655
    reference_title: "Mutations in endothelin 1 cause recessive auriculocondylar syndrome and dominant isolated question-mark ears."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "These findings provide further support for the hypothesis that ACS and QMEs are uniquely caused by disruption of the EDN1-EDNRA signaling pathway."
    explanation: EDN1 mutation discovery supports EDN1-EDNRA pathway disruption as a unifying disease mechanism.
  downstream:
  - target: Mandibular condyle hypoplasia
    description: Impaired mandibular identity specification disrupts condylar development.
  - target: Micrognathia
    description: Mandibular hypoplasia results from abnormal first arch-derived jaw patterning.
  - target: Question mark ear
    description: External ear malformation accompanies first and second arch patterning defects.
- name: Cranial Neural Crest Patterning Defect
  description: >-
    Cranial neural crest cells populate the pharyngeal arches and generate most
    craniofacial bone, cartilage, and connective tissue. In auriculocondylar
    syndrome, disturbed neural crest identity and patterning underlie ear and
    mandibular malformations.
  cell_types:
  - preferred_term: cranial neural crest cell
    term:
      id: CL:0000008
      label: migratory cranial neural crest cell
  biological_processes:
  - preferred_term: neural crest cell migration
    term:
      id: GO:0001755
      label: neural crest cell migration
    modifier: ABNORMAL
  evidence:
  - reference: PMID:24123988
    reference_title: "Understanding the basis of auriculocondylar syndrome: Insights from human, mouse and zebrafish genetic studies."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Affected structures arise from cranial neural crest cells, a population of cells in the embryo that reside in the pharyngeal arches and give rise to most of the bone, cartilage and connective tissue of the face."
    explanation: This review links affected auriculocondylar structures to cranial neural crest-derived tissues.
  - reference: PMID:24123988
    reference_title: "Understanding the basis of auriculocondylar syndrome: Insights from human, mouse and zebrafish genetic studies."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Disruption of this signaling pathway in both mouse and zebrafish results in loss of identity of neural crest cells of the mandibular portion of the first pharyngeal arch and the subsequent repatterning of these cells, leading to homeosis of lower jaw structures into more maxillary-like structures."
    explanation: Mouse and zebrafish evidence supports neural crest mandibular identity loss as a mechanism for the craniofacial phenotype.
  downstream:
  - target: EDN1-EDNRA Craniofacial Signaling Disruption
    description: Developmental patterning defects converge on the EDN1-DLX5/6 mandibular identity program.
- name: Dominant-Negative GNAI3 Dysfunction
  description: >-
    GNAI3 variants cluster around GDP/GTP-binding motifs and are proposed to
    act through a dominant-negative mechanism that interferes with endothelin
    pathway signal transduction during pharyngeal arch development.
  genes:
  - preferred_term: GNAI3
    term:
      id: hgnc:4387
      label: GNAI3
  biological_processes:
  - preferred_term: signal transduction
    term:
      id: GO:0007165
      label: signal transduction
    modifier: DECREASED
  evidence:
  - reference: PMID:25026904
    reference_title: "Novel variants in GNAI3 associated with auriculocondylar syndrome strengthen a common dominant negative effect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Structural modeling shows that all five altered GNAI3 residues identified to date cluster in a region involved in GDP/GTP binding."
    explanation: Variant clustering near GDP/GTP binding supports disrupted GNAI3 signaling function.
  - reference: PMID:25026904
    reference_title: "Novel variants in GNAI3 associated with auriculocondylar syndrome strengthen a common dominant negative effect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We hypothesize that all GNAI3 variants lead to dominant negative effects."
    explanation: The abstract explicitly supports a dominant-negative interpretation for GNAI3 variants.
  downstream:
  - target: EDN1-EDNRA Craniofacial Signaling Disruption
    description: GNAI3 acts as an intracellular effector in the EDN1-EDNRA developmental signaling pathway.
- name: PLCB4 Catalytic Domain Dysfunction
  description: >-
    PLCB4 variants include heterozygous missense variants clustered in protein
    domains and biallelic loss-of-function lesions. Heterozygous missense
    variants are proposed to interfere dominantly rather than act through simple
    haploinsufficiency.
  genes:
  - preferred_term: PLCB4
    term:
      id: hgnc:9059
      label: PLCB4
  biological_processes:
  - preferred_term: signal transduction
    term:
      id: GO:0007165
      label: signal transduction
    modifier: DECREASED
  evidence:
  - reference: PMID:23315542
    reference_title: "Heterogeneity of mutational mechanisms and modes of inheritance in auriculocondylar syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The narrow distribution of mutations within protein space suggests that the mutations may result in dominantly interfering proteins, rather than haploinsufficiency."
    explanation: This supports a dominant-interference mechanism for many heterozygous PLCB4 missense variants.
  - reference: PMID:38618928
    reference_title: "Auriculocondylar syndrome 2 caused by a novel PLCB4 variant in a male Chinese neonate: A case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Trio-based whole-exome sequencing identified a novel missense variant of NM_001377142.1:c.1928C>T (NP_001364071.1:p.Ser643Phe) in the PLCB4 gene, which was predicted to impair the local structural stability with a result that the protein function might be affected."
    explanation: A recent neonatal case supports PLCB4 structural and functional disruption in ARCND2.
  downstream:
  - target: EDN1-EDNRA Craniofacial Signaling Disruption
    description: PLCB4 acts as an intracellular effector in the EDN1-EDNRA developmental signaling pathway.
- name: TWIST1 Regulatory Dosage Disruption
  description: >-
    A 430 kb duplication involving HDAC9 and TWIST1 regulatory elements can
    deregulate TWIST1 expression in neural crest cells and impair neural crest
    migration and osteogenic differentiation.
  genes:
  - preferred_term: TWIST1
    term:
      id: hgnc:12428
      label: TWIST1
  cell_types:
  - preferred_term: neural crest cell
    term:
      id: CL:0011012
      label: neural crest cell
  - preferred_term: mesenchymal stem cell
    term:
      id: CL:0000134
      label: mesenchymal stem cell
  biological_processes:
  - preferred_term: neural crest cell migration
    term:
      id: GO:0001755
      label: neural crest cell migration
    modifier: DECREASED
  evidence:
  - reference: PMID:34750192
    reference_title: "New locus underlying auriculocondylar syndrome (ARCND): 430 kb duplication involving TWIST1 regulatory elements."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "We also identified decreased migration of iPSC-derived neural crest cells together with dysregulation of osteogenic differentiation in iPSC-affected mesenchymal stem cells."
    explanation: Patient iPSC-derived cellular models directly support neural crest migration and osteogenic differentiation defects.
  - reference: PMID:34750192
    reference_title: "New locus underlying auriculocondylar syndrome (ARCND): 430 kb duplication involving TWIST1 regulatory elements."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Our findings support the hypothesis that the 430 kb duplication is causative of the ARCND phenotype in this family and that deregulation of TWIST1 expression during craniofacial development can contribute to the phenotype."
    explanation: The study supports regulatory TWIST1 dosage disruption as an ARCND mechanism.
  downstream:
  - target: Cranial Neural Crest Patterning Defect
    description: TWIST1 regulatory dysregulation impairs neural crest migration and craniofacial differentiation programs.
phenotypes:
- name: Question mark ear
  category: Craniofacial
  frequency: FREQUENT
  description: >-
    A characteristic external ear malformation with a defect or cleft near the
    lobe-helix junction; it may be syndromic or, in some EDN1 families, isolated.
  phenotype_term:
    preferred_term: Question mark ear
    term:
      id: HP:0030022
      label: Question mark ear
  evidence:
  - reference: PMID:24268655
    reference_title: "Mutations in endothelin 1 cause recessive auriculocondylar syndrome and dominant isolated question-mark ears."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Auriculocondylar syndrome (ACS) is a rare craniofacial disorder with mandibular hypoplasia and question-mark ears (QMEs) as major features."
    explanation: This directly supports question mark ears as a major feature.
  - reference: PMID:38618928
    reference_title: "Auriculocondylar syndrome 2 caused by a novel PLCB4 variant in a male Chinese neonate: A case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Micrognathia, microstomia, distinctive question mark ears, as well as mandibular condyle hypoplasia were identified."
    explanation: A recent PLCB4 neonatal case directly documents question mark ears.
- name: Mandibular condyle hypoplasia
  category: Craniofacial
  frequency: FREQUENT
  description: Underdevelopment of the mandibular condyle is part of the defining clinical triad.
  phenotype_term:
    preferred_term: Mandibular condyle hypoplasia
    term:
      id: HP:0007628
      label: Mandibular condyle hypoplasia
  evidence:
  - reference: PMID:39014351
    reference_title: "Novel GNAI3 mutation in a Chinese family with auriculocondylar syndrome and treatment of severe dentofacial deformities: a 5-year follow-up case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "BACKGROUND: Auriculocondylar syndrome (ARCND) is an extremely rare autosomal dominant or recessive condition that typically manifests as question mark ears (QMEs), mandibular condyle hypoplasia, and micrognathia."
    explanation: This recent clinical report directly supports mandibular condyle hypoplasia as a typical manifestation.
  - reference: PMID:28328130
    reference_title: "Targeted molecular investigation in patients within the clinical spectrum of Auriculocondylar syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Auriculocondylar syndrome, mainly characterized by micrognathia, small mandibular condyle, and question mark ears, is a rare disease segregating in an autosomal dominant pattern in the majority of the families reported in the literature."
    explanation: This supports small mandibular condyle as a main disease feature.
- name: Micrognathia
  category: Craniofacial
  frequency: FREQUENT
  description: Developmental mandibular hypoplasia is a core clinical feature.
  phenotype_term:
    preferred_term: Micrognathia
    term:
      id: HP:0000347
      label: Micrognathia
  evidence:
  - reference: PMID:34789173
    reference_title: "Prenatal diagnosis of auriculocondylar syndrome with a novel missense variant of GNAI3: a case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "BACKGROUND: Auriculocondylar syndrome (ACS) is a rare disorder characterized by micrognathia, mandibular condyle hypoplasia, and auricular abnormalities."
    explanation: Prenatal case report directly identifies micrognathia as a core disease characteristic.
  - reference: PMID:34789173
    reference_title: "Prenatal diagnosis of auriculocondylar syndrome with a novel missense variant of GNAI3: a case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Severe micrognathia and mandibular hypoplasia were identified on ultrasonography."
    explanation: This supports prenatal detectability of severe micrognathia.
- name: Microstomia
  category: Craniofacial
  description: A small oral aperture can accompany mandibular and maxillofacial malformations.
  phenotype_term:
    preferred_term: microstomia
  evidence:
  - reference: PMID:38618928
    reference_title: "Auriculocondylar syndrome 2 caused by a novel PLCB4 variant in a male Chinese neonate: A case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Micrognathia, microstomia, distinctive question mark ears, as well as mandibular condyle hypoplasia were identified."
    explanation: The cited neonatal case directly reports microstomia in PLCB4-related ARCND2.
- name: Cleft palate
  category: Craniofacial
  description: Cleft palate is a variable craniofacial feature in auriculocondylar syndrome.
  phenotype_term:
    preferred_term: Cleft palate
    term:
      id: HP:0000175
      label: Cleft palate
  evidence:
  - reference: PMID:22560091
    reference_title: "A human homeotic transformation resulting from mutations in PLCB4 and GNAI3 causes auriculocondylar syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Auriculocondylar syndrome (ACS) is a rare, autosomal-dominant craniofacial malformation syndrome characterized by variable micrognathia, temporomandibular joint ankylosis, cleft palate, and a characteristic \"question-mark\" ear malformation."
    explanation: The original PLCB4/GNAI3 discovery paper includes cleft palate among variable clinical features.
- name: Temporomandibular joint ankylosis
  category: Craniofacial
  description: >-
    Fusion or ankylosis of the temporomandibular joint can restrict jaw opening
    and is part of the original auriculocondylar syndrome clinical description.
  phenotype_term:
    preferred_term: Temporomandibular joint ankylosis
    term:
      id: HP:0012478
      label: Temporomandibular joint ankylosis
  evidence:
  - reference: PMID:22560091
    reference_title: "A human homeotic transformation resulting from mutations in PLCB4 and GNAI3 causes auriculocondylar syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Auriculocondylar syndrome (ACS) is a rare, autosomal-dominant craniofacial malformation syndrome characterized by variable micrognathia, temporomandibular joint ankylosis, cleft palate, and a characteristic \"question-mark\" ear malformation."
    explanation: This original discovery paper directly lists temporomandibular joint ankylosis as a clinical feature.
- name: Respiratory distress
  category: Respiratory
  description: Severe neonatal mandibular and oral malformations can present with respiratory distress.
  phenotype_term:
    preferred_term: Respiratory distress
    term:
      id: HP:0002098
      label: Respiratory distress
  evidence:
  - reference: PMID:38618928
    reference_title: "Auriculocondylar syndrome 2 caused by a novel PLCB4 variant in a male Chinese neonate: A case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The proband, a 5-day-old male neonate, was referred to our hospital for respiratory distress."
    explanation: A recent neonatal ARCND2 case directly documents respiratory distress.
- name: Hearing impairment
  category: Auditory
  description: >-
    Hearing impairment can occur in auriculocondylar syndrome, including
    conductive mechanisms related to middle-ear ossicular malformation.
  phenotype_term:
    preferred_term: Hearing impairment
    term:
      id: HP:0000365
      label: Hearing impairment
  evidence:
  - reference: PMID:22865651
    reference_title: "Ossicular fusion and cholesteatoma in auriculo-condylar syndrome: in vivo evidence of arrest of embryogenesis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We describe a 14-year-old male with constricted pinnae, mandibular dysostosis, glossoptosis, a high-arched palate, hearing loss, and cholesteatoma."
    explanation: This case report directly documents hearing loss in auriculo-condylar syndrome.
  - reference: PMID:22865651
    reference_title: "Ossicular fusion and cholesteatoma in auriculo-condylar syndrome: in vivo evidence of arrest of embryogenesis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Computed tomography imaging demonstrated malleoincudal joint ankylosis."
    explanation: Middle-ear ossicular ankylosis supports a plausible structural basis for conductive hearing impairment.
- name: Polyhydramnios
  category: Prenatal
  description: Polyhydramnios may accompany severe prenatal mandibular hypoplasia.
  phenotype_term:
    preferred_term: polyhydramnios
  evidence:
  - reference: PMID:34789173
    reference_title: "Prenatal diagnosis of auriculocondylar syndrome with a novel missense variant of GNAI3: a case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Severe micrognathia and mandibular hypoplasia accompanied by polyhydramnios are prenatal indicators of ACS."
    explanation: This directly supports polyhydramnios as a prenatal indicator when combined with severe mandibular findings.
- name: Full cheeks
  category: Craniofacial
  description: Full cheeks are associated with molecularly characterized auriculocondylar syndrome.
  phenotype_term:
    preferred_term: Full cheeks
    term:
      id: HP:0000293
      label: Full cheeks
  evidence:
  - reference: PMID:28328130
    reference_title: "Targeted molecular investigation in patients within the clinical spectrum of Auriculocondylar syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We also performed a detailed comparative analysis of the patients presented in this study with those previously published, which showed that the pattern of auricular abnormality and full cheeks were associated with molecularly characterized individuals with Auriculocondylar syndrome."
    explanation: The molecular cohort analysis directly associates full cheeks with molecularly confirmed disease.
genetic:
- name: GNAI3 pathogenic variants
  subtype: ARCND1
  gene_term:
    preferred_term: GNAI3
    term:
      id: hgnc:4387
      label: GNAI3
  association: Causative
  notes: >-
    GNAI3 variants usually affect highly conserved GDP/GTP-binding motifs and
    are interpreted as dominant-negative in reported families.
  evidence:
  - reference: PMID:25026904
    reference_title: "Novel variants in GNAI3 associated with auriculocondylar syndrome strengthen a common dominant negative effect."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Causative variants have been identified in PLCB4, GNAI3 and EDN1, which are predicted to function within the EDN1-EDNRA pathway during early pharyngeal arch patterning."
    explanation: This directly includes GNAI3 among causative genes in the pathway.
  - reference: PMID:39014351
    reference_title: "Novel GNAI3 mutation in a Chinese family with auriculocondylar syndrome and treatment of severe dentofacial deformities: a 5-year follow-up case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A novel insertional mutation in the guanine nucleotide-binding protein alpha-inhibiting activity polypeptide 3 (GNAI3) was identified in the patient and their brother using whole-exome sequencing."
    explanation: A recent family report supports GNAI3 as a causal gene and illustrates WES diagnosis.
- name: PLCB4 pathogenic variants
  subtype: ARCND2A
  gene_term:
    preferred_term: PLCB4
    term:
      id: hgnc:9059
      label: PLCB4
  association: Causative
  notes: >-
    PLCB4 variants are a common molecular cause in investigated ARCND cohorts
    and include both heterozygous missense variants and biallelic loss-of-function
    lesions.
  evidence:
  - reference: PMID:28328130
    reference_title: "Targeted molecular investigation in patients within the clinical spectrum of Auriculocondylar syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "So far, pathogenic variants in PLCB4, GNAI3, and EDN1 have been associated with this syndrome."
    explanation: This cohort paper directly supports PLCB4 as an associated causative gene.
  - reference: PMID:38618928
    reference_title: "Auriculocondylar syndrome 2 caused by a novel PLCB4 variant in a male Chinese neonate: A case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "METHODS: This study reports a case of ARCND2 resulting from a novel pathogenic variant in the PLCB4 gene, and summarizes PLCB4 gene mutation sites and phenotypes of ARCND2."
    explanation: Recent case report directly supports PLCB4 variants as causative for ARCND2.
- name: EDN1 pathogenic variants
  subtype: ARCND3
  gene_term:
    preferred_term: EDN1
    term:
      id: hgnc:3176
      label: EDN1
  association: Causative
  notes: >-
    EDN1 variants can cause recessive syndromic auriculocondylar syndrome or
    dominant isolated question mark ears, consistent with mutation-dependent
    residual endothelin 1 activity.
  evidence:
  - reference: PMID:24268655
    reference_title: "Mutations in endothelin 1 cause recessive auriculocondylar syndrome and dominant isolated question-mark ears."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Targeted sequencing of EDN1 in an ACS individual with related parents identified a fourth, homozygous mutation falling close to the site of cleavage by endothelin-converting enzyme."
    explanation: This supports EDN1 as a causal gene for recessive auriculocondylar syndrome.
- name: TWIST1 regulatory duplication
  subtype: ARCND4
  gene_term:
    preferred_term: TWIST1
    term:
      id: hgnc:12428
      label: TWIST1
  association: Causative
  notes: >-
    The ARCND4 locus is a noncoding structural variant affecting regulatory
    elements that interact with the TWIST1 promoter rather than a coding TWIST1
    variant.
  evidence:
  - reference: PMID:34750192
    reference_title: "New locus underlying auriculocondylar syndrome (ARCND): 430 kb duplication involving TWIST1 regulatory elements."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "This study highlights a fourth locus causative of ARCND, represented by a tandem duplication of 430 kb in a candidate region on chromosome 7 defined by linkage analysis."
    explanation: This directly supports the structural regulatory duplication as a causative ARCND locus.
diagnosis:
- name: Clinical triad recognition
  description: >-
    Clinical diagnosis is anchored by the triad of question mark ears,
    mandibular condyle hypoplasia, and micrognathia, while recognizing that
    partial presentations occur.
  evidence:
  - reference: PMID:39014351
    reference_title: "Novel GNAI3 mutation in a Chinese family with auriculocondylar syndrome and treatment of severe dentofacial deformities: a 5-year follow-up case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "CONCLUSIONS: ARCND is a monogenic and rare condition that can be diagnosed based on its clinical triad of core features."
    explanation: This directly supports clinical triad-based diagnosis.
- name: Molecular testing
  description: >-
    Whole-exome sequencing or targeted testing of ARCND genes can confirm
    diagnosis, especially when clinical features are inconspicuous, atypical, or
    detected prenatally.
  results: Pathogenic or likely pathogenic variants in GNAI3, PLCB4, EDN1, or ARCND4 regulatory CNV.
  evidence:
  - reference: PMID:39014351
    reference_title: "Novel GNAI3 mutation in a Chinese family with auriculocondylar syndrome and treatment of severe dentofacial deformities: a 5-year follow-up case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Molecular diagnosis plays a crucial role in the diagnosis of patients with inconspicuous clinical features."
    explanation: This supports molecular testing for less obvious clinical presentations.
  - reference: PMID:34789173
    reference_title: "Prenatal diagnosis of auriculocondylar syndrome with a novel missense variant of GNAI3: a case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Whole-exome sequencing identified a novel de novo missense variant of c.140G > A in the GNAI3 gene."
    explanation: This supports WES utility in prenatal diagnosis.
prevalence:
- population: General population
  notes: >-
    Ultra-rare; Falcon research and recent reviews cite Orphanet estimates of
    less than 1 in 1,000,000, but no PMID-backed abstract snippet with a numeric
    prevalence was available for validation.
progression:
- phase: Congenital
  duration: Lifelong
  notes: >-
    Craniofacial anomalies are congenital. Severity varies from isolated ear
    anomalies to severe mandibular, oral, airway, feeding, and dental
    complications requiring staged treatment.
  evidence:
  - reference: PMID:34789173
    reference_title: "Prenatal diagnosis of auriculocondylar syndrome with a novel missense variant of GNAI3: a case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Severe micrognathia and mandibular hypoplasia accompanied by polyhydramnios are prenatal indicators of ACS."
    explanation: Prenatal ultrasound evidence supports congenital onset.
treatments:
- name: Multidisciplinary Craniofacial Surgery
  description: >-
    Severe dentofacial deformities may be treated with staged craniofacial
    surgery, including distraction osteogenesis and orthognathic surgery, often
    guided by three-dimensional digital planning.
  treatment_term:
    preferred_term: surgical procedure
    term:
      id: MAXO:0000004
      label: surgical procedure
  target_phenotypes:
  - preferred_term: Micrognathia
    term:
      id: HP:0000347
      label: Micrognathia
  - preferred_term: Mandibular condyle hypoplasia
    term:
      id: HP:0007628
      label: Mandibular condyle hypoplasia
  evidence:
  - reference: PMID:39014351
    reference_title: "Novel GNAI3 mutation in a Chinese family with auriculocondylar syndrome and treatment of severe dentofacial deformities: a 5-year follow-up case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "After a multidisciplinary consultation and examination, sequential orthodontic treatment and craniofacial surgery, including distraction osteogenesis and orthognathic surgery, were performed using three-dimensional (3D) digital technology to treat the patient's dentofacial deformity."
    explanation: This directly supports multidisciplinary staged craniofacial surgical management.
  - reference: PMID:39014351
    reference_title: "Novel GNAI3 mutation in a Chinese family with auriculocondylar syndrome and treatment of severe dentofacial deformities: a 5-year follow-up case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Sequential therapy with preoperative orthodontic treatment combined with distraction osteogenesis and orthognathic surgery guided by 3D digital technology may be a practical and effective method for treating ARCND."
    explanation: The conclusion supports this approach as a practical treatment option for severe ARCND dentofacial deformity.
- name: Distraction Osteogenesis
  description: >-
    Mandibular distraction osteogenesis can be part of staged treatment for
    severe mandibular and airway-related dentofacial deformity.
  treatment_term:
    preferred_term: distraction osteogenesis
    term:
      id: MAXO:0000486
      label: distraction osteogenesis
  target_phenotypes:
  - preferred_term: Micrognathia
    term:
      id: HP:0000347
      label: Micrognathia
  evidence:
  - reference: PMID:39014351
    reference_title: "Novel GNAI3 mutation in a Chinese family with auriculocondylar syndrome and treatment of severe dentofacial deformities: a 5-year follow-up case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Sequential therapy with preoperative orthodontic treatment combined with distraction osteogenesis and orthognathic surgery guided by 3D digital technology may be a practical and effective method for treating ARCND."
    explanation: This directly names distraction osteogenesis as part of effective staged treatment.
- name: Supportive Airway and Feeding Care
  description: >-
    Infants with severe mandibular hypoplasia, microstomia, or respiratory
    distress require individualized supportive airway, feeding, dental, and
    craniofacial specialty care.
  treatment_term:
    preferred_term: supportive care
    term:
      id: MAXO:0000950
      label: supportive care
  target_phenotypes:
  - preferred_term: Respiratory distress
    term:
      id: HP:0002098
      label: Respiratory distress
  evidence:
  - reference: PMID:38618928
    reference_title: "Auriculocondylar syndrome 2 caused by a novel PLCB4 variant in a male Chinese neonate: A case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The proband, a 5-day-old male neonate, was referred to our hospital for respiratory distress."
    explanation: This supports the need to monitor and manage airway complications in severe neonatal presentations.
- name: Genetic Counseling
  description: >-
    Genetic counseling should address autosomal dominant and recessive
    inheritance, incomplete penetrance, variable expressivity, recurrence risk,
    and options for prenatal or family testing when a pathogenic variant is
    known.
  treatment_term:
    preferred_term: genetic counseling
    term:
      id: MAXO:0000079
      label: genetic counseling
  evidence:
  - reference: PMID:34789173
    reference_title: "Prenatal diagnosis of auriculocondylar syndrome with a novel missense variant of GNAI3: a case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A woman with 30 weeks of gestation was referred to genetic counseling for polyhydramnios and fetal craniofacial anomaly."
    explanation: This prenatal case supports the relevance of genetic counseling when fetal craniofacial anomalies suggest ACS.
differential_diagnoses:
- name: Pierre Robin sequence-plus
  description: >-
    Pierre Robin sequence and Pierre Robin sequence-plus overlap through
    micrognathia and clefting, but question mark ears and mandibular condyle
    hypoplasia point toward auriculocondylar syndrome.
  distinguishing_features:
  - Question mark ears
  - Mandibular condyle hypoplasia
  evidence:
  - reference: PMID:28328130
    reference_title: "Targeted molecular investigation in patients within the clinical spectrum of Auriculocondylar syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In order to address these questions, we searched for alterations in PLCB4, GNAI3, and EDN1 in patients with typical Auriculocondylar syndrome (n = 3), Pierre Robin sequence-plus (n = 3), micrognathia with additional craniofacial malformations (n = 4), or non-specific auricular dysplasia (n = 1), which could represent subtypes of Auriculocondylar syndrome."
    explanation: This supports Pierre Robin sequence-plus as part of the clinical differential or spectrum considered in testing.
animal_models:
- species: Mouse
  genotype: Edn1/Ednra/Ece1 pathway loss-of-function
  description: >-
    Mouse endothelin pathway disruption produces mandibular patterning defects
    relevant to the auriculocondylar syndrome mechanism.
  associated_phenotypes:
  - Mandibular defects
  - Neural crest identity loss
  evidence:
  - reference: PMID:24268655
    reference_title: "Mutations in endothelin 1 cause recessive auriculocondylar syndrome and dominant isolated question-mark ears."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Studies in animal models have indicated the essential role of endothelin 1 (EDN1) signaling through the endothelin receptor type A (EDNRA) in patterning the mandibular portion of the first pharyngeal arch."
    explanation: This supports the relevance of mouse endothelin-pathway models to mandibular patterning defects.
- species: Zebrafish
  genotype: Endothelin signaling disruption
  description: >-
    Zebrafish endothelin pathway disruption supports the conserved role of
    endothelin signaling in mandibular neural crest patterning.
  associated_phenotypes:
  - Lower jaw homeosis
  - Neural crest identity loss
  evidence:
  - reference: PMID:24123988
    reference_title: "Understanding the basis of auriculocondylar syndrome: Insights from human, mouse and zebrafish genetic studies."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Disruption of this signaling pathway in both mouse and zebrafish results in loss of identity of neural crest cells of the mandibular portion of the first pharyngeal arch and the subsequent repatterning of these cells, leading to homeosis of lower jaw structures into more maxillary-like structures."
    explanation: This directly supports zebrafish as a mechanistic model for jaw patterning defects.

📚

References & Deep Research

Deep Research

1

Falcon ▸

Disease Characteristics Research Template

Edison Scientific Literature 44 citations 2026-05-10T11:28:33.205786

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on: 1. Key concepts and definitions with current understanding 2. Recent developments and latest research (prioritize 2023-2024 sources) 3. Current applications and real-world implementations 4. Expert opinions and analysis from authoritative sources 5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available. Always prioritize recent, authoritative sources and provide specific citations for all major claims.

Disease Characteristics Research Template

Target Disease

Disease Name: Auriculocondylar Syndrome
MONDO ID: (if available)
Category: Mendelian

Research Objectives

Please provide a comprehensive research report on Auriculocondylar Syndrome covering all of the disease characteristics listed below. This report will be used to populate a disease knowledge base entry. Be thorough and cite primary literature (PMID preferred) for all claims.

For each section, suggested databases/resources are listed. These are the first places you should search for information on each topic.

1. Disease Information

Search first: OMIM, Orphanet, ICD-10/ICD-11, MeSH, PubMed

What is the disease? Provide a concise overview.
What are the key identifiers? (OMIM, Orphanet, ICD-10/ICD-11, MeSH, Mondo)
What are the common synonyms and alternative names?
Is the information derived from individual patients (e.g., EHR) or aggregated disease-level resources?

2. Etiology

Disease Causal Factors: What are the primary causes? (genetic, environmental, infectious, mechanistic)
Risk Factors:

Search first: PubMed, Cochrane Library, UpToDate, clinical guidelines, ClinVar, ClinGen, GWAS Catalog, PheGenI, CTD, CDC, WHO, epidemiological databases
Genetic risk factors (causal variants, susceptibility loci, modifier genes)
Environmental risk factors (toxins, lifestyle, occupational exposures, age, sex, family history)
Protective Factors:

Search first: PubMed, Cochrane Library, clinical trial databases, GWAS Catalog, gnomAD, WHO, CDC, nutrition databases
Genetic protective factors (protective variants, modifier alleles)
Environmental protective factors (diet, lifestyle, exposures that reduce risk)
Gene-Environment Interactions: How do genetic and environmental factors interact to influence disease?

Search first: CTD, PubMed, PheGenI, GxE databases

3. Phenotypes

Search first: HPO (Human Phenotype Ontology), OMIM, Orphanet, PubMed, clinicaltrials.gov, MedDRA, SNOMED CT, DECIPHER, LOINC

For each phenotype, provide: - Phenotype type: symptoms, clinical signs, physical manifestations, behavioral changes, or laboratory abnormalities

For symptoms/signs: HPO, OMIM, Orphanet, PubMed For behavioral changes: HPO, DSM, RDoC (Research Domain Criteria), PubMed For laboratory abnormalities: LOINC, SNOMED CT, LabTests Online, PubMed - Phenotype characteristics: Search first: OMIM, Orphanet, HPO, PubMed - Age of symptom onset (neonatal, childhood, adult-onset, late-onset) - Symptom severity (mild, moderate, severe, variable) - Symptom progression (stable, progressive, episodic, fluctuating) - Frequency among affected individuals (percentage or qualitative) - Quality of life impact: Effects on daily functioning and well-being (per-phenotype when possible) Search first: EQ-5D database, SF-36, WHO QOL databases, PubMed - Suggest HPO (Human Phenotype Ontology) terms for each phenotype

4. Genetic/Molecular Information

Causal Genes: Gene mutations or chromosomal abnormalities responsible for disease (gene symbols, OMIM IDs)

Search first: OMIM, ClinVar, HGMD, Ensembl, NCBI Gene
Pathogenic Variants:
Affected genes (gene symbols, HGNC IDs) > Search first: OMIM, NCBI Gene, Ensembl, HGNC, UniProt, GeneCards
Variant classification (pathogenic, likely pathogenic, VUS per ACMG/AMP guidelines) > Search first: ClinVar, ClinGen, ACMG/AMP guidelines, VarSome
Variant type/class (missense, frameshift, nonsense, splice-site, structural)
Allele frequency in population databases > Search first: gnomAD, 1000 Genomes, ExAC, TOPMed, dbSNP
Somatic vs germline origin > Search first: COSMIC (somatic), ClinVar, ICGC, TCGA
Functional consequences (loss of function, gain of function, dominant negative)
Modifier Genes: Genes that modify disease severity or expression
Epigenetic Information: DNA methylation, histone modifications, chromatin changes affecting disease

Search first: ENCODE, Roadmap Epigenomics, MethBase, DiseaseMeth
Chromosomal Abnormalities: Large-scale genetic changes (aneuploidy, translocations, inversions)

Search first: DECIPHER, ClinVar, ECARUCA, UCSC Genome Browser

5. Environmental Information

Environmental Factors: Non-genetic contributing factors (toxins, radiation, pollution, occupational exposure)

Search first: CTD (Comparative Toxicogenomics Database), TOXNET, PubMed, EPA databases
Lifestyle Factors: Behavioral factors (smoking, diet, exercise, alcohol consumption)

Search first: CDC databases, WHO, PubMed, NHANES
Infectious Agents: If applicable, pathogens causing or triggering disease (bacteria, viruses, fungi, parasites)

Search first: NCBI Taxonomy, ViPR, BV-BRC, MicrobeDB, GIDEON

6. Mechanism / Pathophysiology

Molecular Pathways: Specific signaling cascades or biochemical pathways involved (Wnt, MAPK, mTOR, PI3K-AKT, etc.)

Search first: KEGG, Reactome, WikiPathways, PathBank, BioCyc
Cellular Processes: Cell-level mechanisms (apoptosis, autophagy, cell cycle dysregulation, inflammation, etc.)

Search first: Gene Ontology (GO), Reactome, KEGG, PubMed
Protein Dysfunction: How protein structure or function is altered (misfolding, aggregation, loss of function, gain of function)

Search first: UniProt, PDB (Protein Data Bank), InterPro, Pfam, AlphaFold
Metabolic Changes: Alterations in metabolic processes (energy metabolism, lipid metabolism, amino acid metabolism)

Search first: KEGG, BioCyc, HMDB (Human Metabolome Database), BRENDA
Immune System Involvement: Role of immune response (autoimmunity, immunodeficiency, chronic inflammation)

Search first: ImmPort, Immunome Database, IEDB, Gene Ontology
Tissue Damage Mechanisms: How tissues/ are injured (oxidative stress, ischemia, fibrosis, necrosis)

Search first: PubMed, Gene Ontology, Reactome
Biochemical Abnormalities: Specific molecular defects (enzyme deficiencies, receptor dysfunction, ion channel defects)

Search first: BRENDA, UniProt, KEGG, OMIM, PubMed
Epigenetic Changes: DNA methylation, histone modifications affecting gene expression in disease

Search first: ENCODE, Roadmap Epigenomics, MethBase, DiseaseMeth
Molecular Profiling (if available):
Transcriptomics/gene expression changes > Search first: GEO (Gene Expression Omnibus), ArrayExpress, GTEx, Human Cell Atlas, SRA
Proteomics findings > Search first: PRIDE, ProteomeXchange, Human Protein Atlas, STRING, BioGRID
Metabolomics signatures > Search first: MetaboLights, Metabolomics Workbench, HMDB, METLIN
Lipidomics alterations > Search first: LIPID MAPS, SwissLipids, LipidHome, Metabolomics Workbench
Genomic structural features > Search first: UCSC Genome Browser, Ensembl, NCBI, dbVar, DGV
Advanced Technologies (if applicable):
Single-cell analysis findings (cell-type specific mechanisms, cellular heterogeneity) > Search first: Human Cell Atlas, Single Cell Portal, GEO, CELLxGENE
Spatial transcriptomics findings > Search first: GEO, Spatial Research, Vizgen, 10x Genomics data
Multi-omics integration results > Search first: TCGA, ICGC, cBioPortal, LinkedOmics, PubMed
Functional genomics screens (CRISPR, RNAi) > Search first: DepMap, GenomeRNAi, PubMed, BioGRID ORCS

For each mechanism, describe: - The causal chain from initial trigger to clinical manifestation - Which mechanisms are upstream vs downstream - What cell types and biological processes are involved - Suggest GO terms for biological processes and CL terms for cell types

7. Anatomical Structures Affected

Organ Level:
Primary organs directly affected
Secondary organ involvement (complications, secondary effects)
Body systems involved (cardiovascular, nervous, digestive, respiratory, endocrine, etc.)

Search first: Uberon, FMA (Foundational Model of Anatomy), OMIM, HPO, ICD-11, MeSH, SNOMED CT
Tissue and Cell Level:
Specific tissue types affected (epithelial, connective, muscle, nervous)
Specific cell populations targeted (with Cell Ontology terms)

Search first: Uberon, Human Protein Atlas, Cell Ontology, Human Cell Atlas, CellMarker, PanglaoDB
Subcellular Level:
Cellular compartments involved (mitochondria, nucleus, ER, lysosomes) (with GO Cellular Component terms)

Search first: Gene Ontology (Cellular Component), UniProt, Human Protein Atlas
Localization:
Specific anatomical sites (with UBERON terms) > Search first: FMA, Uberon, NeuroNames (for brain), SNOMED CT
Lateralization (unilateral, bilateral, asymmetric) > Search first: HPO, clinical literature, imaging databases

8. Temporal Development

Onset:
Typical age of onset (congenital, pediatric, adult, geriatric)
Onset pattern (acute, subacute, chronic, insidious)

Search first: OMIM, Orphanet, HPO, PubMed
Progression:
Disease stages (early, intermediate, advanced, end-stage) > Search first: Cancer Staging Manual (AJCC), WHO classifications, PubMed
Progression rate (rapid, slow, variable)
Disease course pattern (episodic, relapsing-remitting, progressive, stable)
Disease duration (self-limited, chronic lifelong)

Search first: Disease registries, longitudinal cohort databases, natural history studies, PubMed, Orphanet, OMIM
Patterns:
Remission patterns (spontaneous, treatment-induced) > Search first: Clinical trial databases, disease registries, PubMed
Critical periods (time windows of vulnerability or opportunity for intervention) > Search first: PubMed, developmental biology databases, clinical guidelines

9. Inheritance and Population

Epidemiology:
Prevalence (cases per 100,000 at given time)
Incidence (new cases per 100,000 per year)

Search first: Orphanet, CDC, WHO, GBD (Global Burden of Disease), national registries, SEER, disease registries
For Genetic Etiology:
Inheritance pattern (AD, AR, X-linked, mitochondrial, multifactorial, polygenic) > Search first: OMIM, Orphanet, ClinVar, GTR (Genetic Testing Registry)
Penetrance (complete, incomplete, age-dependent) > Search first: ClinVar, OMIM, PubMed, ClinGen
Expressivity (variable, consistent) > Search first: OMIM, ClinVar, PubMed
Genetic anticipation (increasing severity in successive generations) > Search first: OMIM, PubMed (especially for repeat expansion disorders)
Germline mosaicism > Search first: ClinVar, OMIM, genetic counseling literature, PubMed
Founder effects (population-specific mutations) > Search first: gnomAD, population genetics databases, PubMed
Consanguinity role > Search first: OMIM, population studies, genetic counseling resources
Carrier frequency > Search first: gnomAD, carrier screening databases, GeneReviews, GTR
Population Demographics:
Affected populations (ethnic or demographic groups with higher prevalence) > Search first: gnomAD, 1000 Genomes, PAGE Study, PubMed, population registries
Geographic distribution (endemic areas, regional variation) > Search first: WHO, CDC, GBD, Orphanet, geographic epidemiology databases
Geographic distribution of specific variants
Sex ratio (male:female) > Search first: Disease registries, OMIM, PubMed, epidemiological databases
Age distribution of affected individuals > Search first: CDC, disease registries, SEER, Orphanet

10. Diagnostics

Clinical Tests:
Laboratory tests (blood, urine, tissue chemistry, specific enzyme assays) > Search first: LOINC, LabTests Online, PubMed
Biomarkers (proteins, metabolites, genetic markers, circulating biomarkers) > Search first: FDA Biomarker List, BEST (Biomarkers, EndpointS, and other Tools), PubMed
Imaging studies (X-ray, CT, MRI, PET, ultrasound) > Search first: RadLex, DICOM, Radiopaedia, imaging databases
Functional tests (pulmonary function, cardiac stress tests) > Search first: LOINC, clinical guidelines, PubMed
Electrophysiology (EEG, EMG, ECG, nerve conduction studies) > Search first: LOINC, clinical neurophysiology databases, PubMed
Biopsy findings (histopathology, immunohistochemistry) > Search first: SNOMED CT, College of American Pathologists resources, PubMed
Pathology findings (microscopic examination) > Search first: SNOMED CT, Digital Pathology databases, PubMed
Genetic Testing:

Search first: GTR (Genetic Testing Registry), GeneReviews, ClinGen
Overview of recommended genetic testing approach
Whole genome sequencing (WGS) utility > Search first: GTR, ClinVar, GEL (Genomics England), gnomAD
Whole exome sequencing (WES) utility > Search first: GTR, ClinVar, OMIM, GeneMatcher
Gene panels (which panels, which genes) > Search first: GTR, ClinVar, laboratory-specific databases
Single gene testing > Search first: GTR, ClinVar, OMIM, GeneReviews
Chromosomal microarray (CMA) > Search first: DECIPHER, ClinVar, dbVar, ECARUCA
Karyotyping > Search first: Chromosome Abnormality Database, ClinVar, cytogenetics resources
FISH > Search first: ClinVar, cytogenetics databases, PubMed
Mitochondrial DNA testing > Search first: MITOMAP, MSeqDR, ClinVar, GTR
Repeat expansion testing > Search first: GTR, ClinVar, repeat expansion databases, PubMed
Omics-Based Diagnostics (if applicable):
RNA sequencing / transcriptomics > Search first: GEO, ArrayExpress, GTEx, RNA-seq databases
Proteomics > Search first: PRIDE, ProteomeXchange, FDA Biomarker database
Metabolomics > Search first: MetaboLights, Metabolomics Workbench, HMDB
Epigenomics > Search first: GEO, ENCODE, Roadmap Epigenomics, MethBase
Liquid biopsy > Search first: COSMIC, ClinVar, liquid biopsy databases, PubMed
Clinical Criteria:
Standardized diagnostic criteria (DSM, ICD, society guidelines) > Search first: DSM-5, ICD-11, clinical society guidelines, UpToDate
Differential diagnosis (other conditions to rule out, with distinguishing features) > Search first: DynaMed, UpToDate, clinical decision support systems
Screening:
Screening methods for asymptomatic individuals (newborn screening, carrier screening, cascade screening) > Search first: ACMG recommendations, CDC newborn screening, GTR

11. Outcome/Prognosis

Survival and Mortality:
Survival rate (5-year, 10-year, overall) > Search first: SEER, cancer registries, disease-specific registries, PubMed
Life expectancy (with and without treatment if applicable) > Search first: Orphanet, disease registries, actuarial databases, PubMed
Mortality rate > Search first: CDC, WHO, GBD, national mortality databases
Disease-specific mortality (deaths directly attributable to disease) > Search first: Disease registries, CDC Wonder, GBD, PubMed
Morbidity and Function:
Morbidity (disease-related disability and health impacts) > Search first: GBD, WHO, disability databases, PubMed
Disability outcomes (long-term functional impairments) > Search first: ICF (International Classification of Functioning), disability registries
Quality of life measures (EQ-5D, SF-36, PROMIS, disease-specific tools) > Search first: EQ-5D database, SF-36, PROMIS, PubMed
Disease Course:
Complications (secondary problems: infections, organ failure, etc.) > Search first: ICD codes, disease registries, clinical databases, PubMed
Recovery potential (likelihood and extent of recovery, with vs without treatment) > Search first: Natural history studies, rehabilitation databases, PubMed
Prediction:
Prognostic factors (age, disease severity, biomarkers, treatment response) > Search first: Prognostic models databases, clinical calculators, PubMed
Prognostic biomarkers (molecular markers predicting disease course) > Search first: FDA Biomarker database, PubMed, cancer prognostic databases

12. Treatment

Pharmacotherapy:
Pharmacological treatments (drug names, drug classes, mechanisms of action) > Search first: DrugBank, RxNorm, ATC classification, DailyMed, FDA databases
Pharmacogenomics (how genetic variants affect drug metabolism, efficacy, toxicity) > Search first: PharmGKB, CPIC (Clinical Pharmacogenetics), FDA Table of PGx Biomarkers
Advanced Therapeutics:
Gene therapy (viral vectors, CRISPR, gene replacement, gene editing) > Search first: ClinicalTrials.gov, FDA gene therapy database, ASGCT resources
Cell therapy (stem cell transplant, CAR-T, cellular therapeutics) > Search first: ClinicalTrials.gov, FDA cell therapy database, FACT standards
RNA-based therapies (ASOs, siRNA, mRNA therapies) > Search first: ClinicalTrials.gov, FDA approvals, PubMed
Targeted therapies (treatments directed at specific molecular targets) > Search first: My Cancer Genome, OncoKB, ClinicalTrials.gov, FDA approvals
Immunotherapies (checkpoint inhibitors, monoclonal antibodies) > Search first: Cancer Immunotherapy Database, FDA approvals, ClinicalTrials.gov
Surgical and Interventional:
Surgical interventions (types of surgery, timing, outcomes) > Search first: CPT codes, surgical registries, clinical guidelines, PubMed
Supportive and Rehabilitative:
Supportive care (symptom management, pain control, nutrition) > Search first: Clinical guidelines, Cochrane Library, PubMed
Rehabilitation (physical therapy, occupational therapy, speech therapy) > Search first: Rehabilitation medicine databases, clinical guidelines, PubMed
Experimental:
Experimental treatments in clinical trials (with NCT identifiers if available) > Search first: ClinicalTrials.gov, EU Clinical Trials Register, WHO ICTRP
Treatment Outcomes:
Treatment response rates > Search first: Clinical trial databases, FDA reviews, systematic reviews, PubMed
Side effects and adverse events > Search first: FDA Adverse Event Reporting System (FAERS), MedWatch, PubMed
Treatment Strategy:
Treatment algorithms (clinical pathways, decision trees) > Search first: Clinical practice guidelines, NCCN Guidelines, UpToDate
Combination therapies > Search first: ClinicalTrials.gov, treatment guidelines, PubMed
Personalized medicine approaches (genotype-guided treatment) > Search first: My Cancer Genome, CIViC, PharmGKB, precision medicine databases

For each treatment, suggest MAXO (Medical Action Ontology) terms where applicable.

13. Prevention

Prevention Levels:
Primary prevention (preventing disease occurrence: vaccination, risk factor modification) > Search first: CDC, WHO, USPSTF recommendations, Cochrane Library
Secondary prevention (early detection and treatment: screening programs, early intervention) > Search first: USPSTF, CDC screening guidelines, WHO
Tertiary prevention (preventing complications in those with disease) > Search first: Clinical guidelines, disease management protocols, PubMed
Immunization: Vaccine strategies (if applicable)

Search first: CDC vaccine schedules, WHO immunization, FDA vaccine database
Screening and Early Detection:
Screening programs (population-based: newborn screening, cancer screening) > Search first: CDC screening programs, USPSTF, cancer screening databases
Genetic screening (carrier screening, preimplantation genetic diagnosis, prenatal testing) > Search first: ACMG recommendations, ACOG guidelines, GTR
Risk stratification (identifying high-risk individuals for targeted prevention) > Search first: Risk prediction models, clinical calculators, PubMed
Behavioral Interventions: Lifestyle modifications to reduce risk

Search first: CDC, WHO, behavioral intervention databases, Cochrane Library
Counseling: Genetic counseling (risk assessment, family planning guidance)

Search first: NSGC resources, ACMG guidelines, GeneReviews
Public Health:
Public health interventions (sanitation, vector control, health education) > Search first: CDC, WHO, public health databases, PubMed
Environmental interventions (reducing environmental risk factors) > Search first: EPA databases, WHO environmental health, PubMed
Prophylaxis: Preventive medications or procedures

Search first: Clinical guidelines, FDA approvals, PubMed

14. Other Species / Natural Disease

Taxonomy: Species affected (with NCBI Taxon identifiers)

Search first: NCBI Taxonomy
Breed: Specific breeds affected (with VBO identifiers if applicable)

Search first: VBO (Vertebrate Breed Ontology)
Gene: Orthologous genes in other species (with NCBI Gene IDs)

Search first: NCBI Gene
Natural Disease:
Naturally occurring disease in other species (companion animals, wildlife) > Search first: OMIA (Online Mendelian Inheritance in Animals), VetCompass, PubMed
Veterinary relevance and importance in animal health > Search first: OMIA, veterinary databases, PubMed
Comparative Biology:
Comparative pathology (similarities and differences across species) > Search first: OMIA, comparative pathology databases, PubMed
Evolutionary conservation of disease mechanisms > Search first: HomoloGene, OrthoMCL, Alliance of Genome Resources
Transmission (if applicable):
Zoonotic potential > Search first: CDC zoonotic diseases, WHO zoonoses, GIDEON
Cross-species susceptibility > Search first: NCBI Taxonomy, veterinary databases, PubMed

15. Model Organisms

Model Types:
Model organism type (mammalian, invertebrate, cellular, in vitro) > Search first: Alliance of Genome Resources, model organism databases
Specific model systems (mouse, rat, zebrafish, Drosophila, C. elegans, yeast, cell lines, organoids, iPSCs) > Search first: MGI, RGD, ZFIN, FlyBase, WormBase, SGD, ATCC, Cellosaurus
Induced models (drug treatment, surgical intervention, environmental manipulation) > Search first: MGI, model organism databases, PubMed
Genetic Models:
Types available (knockout, knock-in, transgenic, conditional, humanized) > Search first: MGI, IMPC, KOMP, EuMMCR, IMSR
Model Characteristics:
Phenotype recapitulation (how well model reproduces human disease features) > Search first: Model organism databases, comparative studies, PubMed
Model limitations (aspects of human disease not captured) > Search first: Model organism databases, PubMed, review articles
Applications:
Research applications (what aspects of disease can be studied) > Search first: Model organism databases, PubMed
Resources:
Model databases > Search first: MGI, RGD, ZFIN, FlyBase, WormBase, IMSR, EMMA, MMRRC

Citation Requirements

Cite primary literature (PMID preferred) for all mechanistic and clinical claims
Prioritize recent reviews and landmark papers
Include direct quotes from abstracts where possible to support key statements
Distinguish evidence source types: human clinical, model organism, in vitro, computational

Output Format

Structure your response as a comprehensive narrative organized by the sections above. For each section, provide: - Factual content with specific details (numbers, percentages, gene names, variant nomenclature) - Ontology term suggestions (HPO, GO, CL, UBERON, CHEBI, MAXO, MONDO) where applicable - Evidence citations with PMIDs - Direct quotes from abstracts to support key claims - Clear indication when information is not available or not applicable for this disease

This report will be used to populate a disease knowledge base entry with: - Pathophysiology descriptions with causal chains - Gene/protein annotations (HGNC, GO terms) - Phenotype associations (HP terms) with frequencies - Cell type involvement (CL terms) - Anatomical locations (UBERON terms) - Chemical entities (CHEBI terms) - Treatment annotations (MAXO terms) - Evidence items with PMIDs and exact abstract quotes - Epidemiology, prognosis, diagnostic, and prevention information - Animal model descriptions with phenotype recapitulation details

Auriculocondylar Syndrome (ARCND/ACS): Comprehensive Disease Characteristics Report

Executive summary

Auriculocondylar syndrome (ARCND; historically “auriculocondylar syndrome/ACS”) is an ultra-rare congenital craniofacial malformation of first and second pharyngeal arch derivatives, classically presenting with micrognathia, mandibular condyle hypoplasia, and a characteristic external ear anomaly termed the question-mark ear (QME). Current genetic understanding centers on disruption of EDN1–EDNRA signaling and downstream cranial neural crest patterning (DLX5/6), with additional genetic heterogeneity including a regulatory duplication affecting TWIST1 expression. Recent (2024) reports emphasize multidisciplinary, technology-assisted craniofacial care (3D planning, distraction osteogenesis, orthognathic surgery) with measurable functional improvement. (clouthier2013understandingthebasis pages 1-3, rieder2012ahumanhomeotic pages 1-2, shi2024novelgnai3mutation pages 2-6)

1. Disease information

1.1 Definition and current understanding

ARCND/ACS is a rare congenital craniofacial disorder affecting development of the outer ear and mandible, and is best recognized as a disorder of pharyngeal arch (branchial arch) development with a characteristic “homeotic” patterning disturbance of the jaw in severe cases. The core/typical triad is consistently described as micrognathia, mandibular condyle hypoplasia, and a QME defect at the helix–lobule junction. (clouthier2013understandingthebasis pages 1-3, gordon2013heterogeneityofmutational pages 1-2)

Primary literature definition examples: - Rieder et al. (2012) describe ACS as “a rare, autosomal-dominant craniofacial malformation syndrome” with micrognathia and a distinctive QME, and report additional features including TMJ ankylosis and cleft palate. (https://doi.org/10.1016/j.ajhg.2012.04.002; May 2012) (rieder2012ahumanhomeotic pages 1-2) - Clouthier et al. (2013) define the “core triad” as “micrognathia, mandibular condyle hypoplasia, and a unique ear malformation” (QME/Cosman ear). (https://doi.org/10.1002/ajmg.c.31376; Nov 2013) (clouthier2013understandingthebasis pages 1-3)

1.2 Key identifiers (available in retrieved evidence)

A subset of identifiers could be extracted directly from retrieved sources (others were not present in the evidence captured in this run).

Disease / concept	Synonyms / related names in evidence	Identifiers in evidence	Prevalence / epidemiology note in evidence	Source year	URL	Citation
Auriculocondylar syndrome	Auriculocondylar syndrome; ACS; ARCND	MONDO: MONDO_0000107	Open Targets lists MONDO_0000107 for “auriculocondylar syndrome”	n/a	n/a	(OpenTargets Search: Auriculocondylar syndrome)
Auriculocondylar syndrome	“question mark ear syndrome”; “dysgnathia complex”	OMIM #602483, #614669, #615706	Rare / prevalence not given in this excerpt	2013	https://doi.org/10.1002/ajmg.c.31376	(clouthier2013understandingthebasis pages 1-3)
Auriculocondylar syndrome (general ARCND)	ARCND; “question mark ear syndrome”	OMIM #602483, #614669, #615706	Orphanet prevalence stated as under 1 in 1,000,000	2022	https://doi.org/10.1136/jmedgenet-2021-107825	(tavares2022newlocusunderlying pages 1-2)
Auriculocondylar syndrome (general ARCND)	ARCND	OMIM #602483, #614669, #615706	Prevalence stated as less than 1 in 1,000,000; fewer than 100 cases reported	2024	https://doi.org/10.1186/s12903-024-04575-1	(shi2024novelgnai3mutation pages 1-2)
Auriculocondylar syndrome	ARCND; dysgnathia complex; question mark ear syndrome	ARCND1 OMIM #602483; ARCND2A OMIM #614669; ARCND2B OMIM #620458; ARCND3 OMIM #615706; ARCND4 OMIM #620457	Orphanet prevalence stated as under 1/1,000,000	2024	https://doi.org/10.1002/mgg3.2441	(zhang2024auriculocondylarsyndrome2 pages 1-2)
Auriculocondylar syndrome 1	ARCND1	OMIM #602483	Subtype listed in review-style case report evidence	2024	https://doi.org/10.1002/mgg3.2441	(zhang2024auriculocondylarsyndrome2 pages 1-2)
Auriculocondylar syndrome 2A	ARCND2A	OMIM #614669	Subtype listed in review-style case report evidence	2024	https://doi.org/10.1002/mgg3.2441	(zhang2024auriculocondylarsyndrome2 pages 1-2)
Auriculocondylar syndrome 2B	ARCND2B	OMIM #620458; MONDO_0957544	Subtype listed; Open Targets includes MONDO_0957544	2024 / n/a	https://doi.org/10.1002/mgg3.2441	(zhang2024auriculocondylarsyndrome2 pages 1-2, OpenTargets Search: Auriculocondylar syndrome)
Auriculocondylar syndrome 3	ARCND3	OMIM #615706	Subtype listed in review-style case report evidence	2024	https://doi.org/10.1002/mgg3.2441	(zhang2024auriculocondylarsyndrome2 pages 1-2)
Auriculocondylar syndrome 4	ARCND4	OMIM #620457; MONDO_0957543	Subtype listed; Open Targets includes MONDO_0957543 for auriculocondylar syndrome 4	2024 / n/a	https://doi.org/10.1002/mgg3.2441	(zhang2024auriculocondylarsyndrome2 pages 1-2, OpenTargets Search: Auriculocondylar syndrome)
Isolated question-mark ear	Isolated QME; isolated question-mark ears; IQME	OMIM #612798	May occur as isolated anomaly distinct from syndromic ACS	2013	https://doi.org/10.1002/ajmg.c.31376	(clouthier2013understandingthebasis pages 1-3)

Table: This table summarizes disease names, synonyms, and identifiers for auriculocondylar syndrome and related entities using only the evidence retrieved in the session. It highlights subtype OMIM numbers, available MONDO mappings, and prevalence statements useful for a knowledge-base entry.

MONDO: OpenTargets maps “auriculocondylar syndrome” to MONDO_0000107, and includes MONDO entries for ARCND subtypes (e.g., auriculocondylar syndrome 4). (OpenTargets Search: Auriculocondylar syndrome)

OMIM (disease): OMIM IDs commonly cited include 602483, 614669, 615706, and for ARCND subtype breakdown: ARCND1 #602483; ARCND2A #614669; ARCND2B #620458; ARCND3 #615706; ARCND4 #620457. (zhang2024auriculocondylarsyndrome2 pages 1-2, clouthier2013understandingthebasis pages 1-3, tavares2022newlocusunderlying pages 1-2)

OMIM (related phenotype): Isolated question-mark ear (IQME) OMIM 612798. (clouthier2013understandingthebasis pages 1-3)

Orphanet: Multiple sources cite Orphanet as the prevalence source and provide the Orphanet homepage URL (http://www.orpha.net). (tavares2022newlocusunderlying pages 1-2, zhang2024auriculocondylarsyndrome2 pages 1-2)

ICD-10/ICD-11 and MeSH: Specific ICD-10/ICD-11 codes and MeSH headings were not present in the retrieved text evidence and therefore cannot be asserted here.

1.3 Synonyms and alternative names

Common synonyms in the retrieved literature include: - “question mark ear syndrome” (clouthier2013understandingthebasis pages 1-3, tavares2022newlocusunderlying pages 1-2) - “dysgnathia complex” (zhang2024auriculocondylarsyndrome2 pages 1-2, clouthier2013understandingthebasis pages 1-3)

1.4 Evidence sources (individual vs aggregated)

Evidence in this report derives from: - Aggregated disease-level resources and synthesis: a Seminars review integrating human, mouse, and zebrafish genetics (Clouthier et al., 2013). (clouthier2013understandingthebasis pages 1-3) - Primary human genetics (families/case series): e.g., Rieder et al. 2012 (exome + functional assays), Gordon et al. 2013 (EDN1), Tavares et al. 2017 (molecular cohort statistics), Tavares et al. 2022 (CNV + iPSC modeling). (rieder2012ahumanhomeotic pages 1-2, gordon2013mutationsinendothelin pages 1-2, tavares2017targetedmolecularinvestigation pages 4-6, tavares2022newlocusunderlying pages 5-6) - Recent individual clinical implementations (case reports): 2024 ARCND management with orthodontics + distraction + orthognathic surgery and 5-year outcomes. (shi2024novelgnai3mutation pages 2-6)

2. Etiology

2.1 Disease causal factors (primary causes)

ARCND is primarily a genetic (Mendelian) craniofacial developmental disorder, caused by pathogenic variants that disrupt endothelin signaling in cranial neural crest and related patterning programs. (clouthier2013understandingthebasis pages 1-3, rieder2012ahumanhomeotic pages 1-2)

Major established causal genes/loci in retrieved evidence: - PLCB4 (ARCND2; most common cause in molecular cohorts) (tavares2017targetedmolecularinvestigation pages 4-6) - GNAI3 (ARCND1) (tavares2015novelvariantsin pages 1-2, shi2024novelgnai3mutation pages 2-6) - EDN1 (ARCND3; ligand-level defect) (gordon2013mutationsinendothelin pages 1-2) - 430 kb tandem duplication at HDAC9/TWIST1 regulatory landscape (ARCND4; regulatory mechanism) (tavares2022newlocusunderlying pages 5-6, tavares2022newlocusunderlying pages 4-4)

2.2 Risk factors

Genetic risk factors (causal variants)

Molecular cohort data: In a cohort of 28 molecularly investigated index patients, 16/28 (57.1%) carried PLCB4 variants, 6/28 (21.4%) carried GNAI3 variants, 4/28 (14.3%) carried EDN1 variants, and 2/28 (7.1%) were unsolved. (Tavares et al., 2017; https://doi.org/10.1002/ajmg.a.38101; Apr 2017) (tavares2017targetedmolecularinvestigation pages 4-6)

EDN1 can cause recessive ACS and dominant isolated QME depending on the mutation and residual EDN1 activity. (Gordon et al., 2013; https://doi.org/10.1016/j.ajhg.2013.10.023; Dec 2013) (gordon2013mutationsinendothelin pages 1-2)

Representative variants are summarized in the genetics table artifact below.

ARCND subtype (if known)	Gene/locus	Inheritance patterns reported	Variant examples (HGVS when available)	Proposed mechanism	Key functional evidence	Primary sources with year/URL
ARCND1	GNAI3	AD; incomplete penetrance reported in some families	c.118G>C, p.Gly40Arg; p.Ser47Arg; p.Gly45Val; p.Thr48Asn; p.Asn269Tyr; c.140G>A, p.Ser47Asn; c.144_145insCATTGTGAAACAGATGAA, p.T48_I49insHCETDE (rieder2012ahumanhomeotic pages 3-5, tavares2016identificaçãodenovas pages 67-68, liu2021prenataldiagnosisof pages 1-3, shi2024novelgnai3mutation pages 2-6)	Predominantly dominant-negative disruption of GTP/GDP-binding region in the G1/G4 motifs, impairing downstream endothelin signaling (gordon2013heterogeneityofmutational pages 11-12, tavares2015novelvariantsin pages 1-2)	Structural modeling placed pathogenic residues in the nucleotide-binding pocket; p.Gly40Arg predicted to stabilize aberrant active conformation and inhibit MAPK/Rap signaling; patient-derived osteoblast assays in ACS showed reduced DLX5/DLX6 expression consistent with EDN1-pathway disruption (rieder2012ahumanhomeotic pages 3-5, rieder2012ahumanhomeotic pages 1-2, tavares2015novelvariantsin pages 1-2)	Rieder et al., 2012, https://doi.org/10.1016/j.ajhg.2012.04.002; Tavares et al., 2015, https://doi.org/10.1038/ejhg.2014.132; Liu et al., 2021, https://doi.org/10.1186/s12884-021-04238-x; Shi et al., 2024, https://doi.org/10.1186/s12903-024-04575-1 (rieder2012ahumanhomeotic pages 3-5, tavares2015novelvariantsin pages 1-2, liu2021prenataldiagnosisof pages 1-3, shi2024novelgnai3mutation pages 2-6)
ARCND2A	PLCB4	AD	c.986A>C, p.Asn329Ser; p.Arg621His; p.Arg621Cys; p.Tyr623Cys; p.Asn650His; c.1072G>C, p.Glu358Gln; c.983A>G, p.His328Arg; c.1928C>T, p.Ser643Phe; p.Asp360Asn; p.Arg621Leu (rieder2012ahumanhomeotic pages 3-5, tavares2017targetedmolecularinvestigation pages 4-6, tavares2016identificaçãodenovas pages 67-68, zhang2024auriculocondylarsyndrome2 pages 2-5)	Mostly dominant-negative catalytic-domain dysfunction rather than simple haploinsufficiency (gordon2013heterogeneityofmutational pages 11-12)	Variants cluster in X/Y catalytic domains; structural modeling predicted impaired PLC catalytic activity and disturbed IP3 generation without gross protein destabilization; ACS osteoblasts showed reduced DLX5/DLX6 expression; PLCB4 accounts for ~57.1% of molecularly solved index cases in one cohort (16/28) (rieder2012ahumanhomeotic pages 3-5, rieder2012ahumanhomeotic pages 1-2, tavares2017targetedmolecularinvestigation pages 4-6)	Rieder et al., 2012, https://doi.org/10.1016/j.ajhg.2012.04.002; Gordon et al., 2013, https://doi.org/10.1136/jmedgenet-2012-101331; Tavares et al., 2017, https://doi.org/10.1002/ajmg.a.38101; Zhang et al., 2024, https://doi.org/10.1002/mgg3.2441 (rieder2012ahumanhomeotic pages 3-5, gordon2013heterogeneityofmutational pages 11-12, tavares2017targetedmolecularinvestigation pages 4-6, zhang2024auriculocondylarsyndrome2 pages 2-5)
ARCND2B	PLCB4	AR	Intragenic homozygous deletion; compound heterozygous splice variants c.854-1G>A and c.1238+1G>C; homozygous loss-of-function PLCB4 alleles also reported in review tables (tavares2016identificaçãodenovas pages 67-68, tavares2016identificaçãodenovas pages 68-72)	Loss-of-function / splice-null mechanism (tavares2016identificaçãodenovas pages 68-72, gordon2013heterogeneityofmutational pages 11-12)	Human recessive cases demonstrate that complete PLCB4 loss can produce classical ACS craniofacial features, contrasting with lack of craniofacial phenotype in some mouse null models; 13.3% (2/15) of PLCB4 variants in one summary were homozygous predicted LoF (gordon2013heterogeneityofmutational pages 11-12, tavares2016identificaçãodenovas pages 68-72)	Gordon et al., 2013, https://doi.org/10.1136/jmedgenet-2012-101331; Tavares thesis, 2016, https://doi.org/10.11606/t.41.2016.tde-14072016-142513 (gordon2013heterogeneityofmutational pages 11-12, tavares2016identificaçãodenovas pages 68-72, tavares2016identificaçãodenovas pages 67-68)
ARCND3	EDN1	AR for syndromic ACS; AD for isolated question-mark ears	Homozygous proprotein cleavage-site substitutions in ACS; AD EDN1 variants reported include p.Val64Asp and p.Tyr83*; homozygous c.271A>G, p.Lys91Glu reported in consanguineous ACS cases (gordon2013mutationsinendothelin pages 1-2, tavares2016identificaçãodenovas pages 67-68)	Reduced or altered EDN1 ligand activity with mutation-dependent residual function; upstream endothelin-pathway defect (gordon2013mutationsinendothelin pages 1-2)	Mouse data show Edn1/Ednra/Ece1 loss causes severe mandibular defects; human EDN1 mutations establish ligand-level causation upstream of PLCB4/GNAI3; differing inheritance for ACS vs isolated QME likely reflects residual EDN1 activity (gordon2013mutationsinendothelin pages 1-2)	Gordon et al., 2013, https://doi.org/10.1016/j.ajhg.2013.10.023 (gordon2013mutationsinendothelin pages 1-2)
ARCND4	7p locus involving HDAC9/TWIST1 regulatory elements	AD in reported pedigree	Tandem duplication NC_000007.14:g.18437239_18867540dup (430,302 bp), telomeric to TWIST1 and covering most of HDAC9 (tavares2022newlocusunderlying pages 4-4)	Regulatory mechanism: altered cis-regulation of TWIST1 and disruption/duplication of HDAC9 isoforms rather than coding mutation in known ARCND genes (tavares2022newlocusunderlying pages 1-1, tavares2022newlocusunderlying pages 4-4)	Capture-C showed duplicated region contacts the TWIST1 promoter; patient iPSC-derived neural crest cells had increased HDAC9 (3.15-fold) and TWIST1 (2.03-fold), ~4.3-fold reduced NCC migration, and impaired osteogenic differentiation with ~20.3-fold reduced ALP activity and reduced matrix mineralization; linkage LOD 2.88 (tavares2022newlocusunderlying pages 5-6, tavares2022newlocusunderlying pages 6-7, tavares2022newlocusunderlying pages 4-4)	Tavares et al., 2022, https://doi.org/10.1136/jmedgenet-2021-107825 (tavares2022newlocusunderlying pages 1-1, tavares2022newlocusunderlying pages 5-6, tavares2022newlocusunderlying pages 6-7, tavares2022newlocusunderlying pages 4-4)
Unsolved / residual ARCND fraction	Unknown locus/loci	Likely mixed	No pathogenic variants found in known genes in 2/28 index patients in one cohort; historical reports also noted unsolved families before discovery of the HDAC9/TWIST1 duplication (tavares2017targetedmolecularinvestigation pages 4-6, tavares2022newlocusunderlying pages 1-1)	Genetic heterogeneity; additional loci remain plausible (tavares2017targetedmolecularinvestigation pages 4-6)	Cohort data: 16/28 PLCB4, 6/28 GNAI3, 4/28 EDN1, and 2/28 unexplained; discovery of ARCND4 reduced but did not eliminate unsolved disease fraction (tavares2017targetedmolecularinvestigation pages 4-6, tavares2022newlocusunderlying pages 1-1)	Tavares et al., 2017, https://doi.org/10.1002/ajmg.a.38101; Tavares et al., 2022, https://doi.org/10.1136/jmedgenet-2021-107825 (tavares2017targetedmolecularinvestigation pages 4-6, tavares2022newlocusunderlying pages 1-1)

Table: This table summarizes the currently reported genetic causes and loci for auriculocondylar syndrome, linking subtypes to representative variants, inheritance, and proposed molecular mechanisms. It is useful for quickly comparing coding-gene causes in the EDN1 pathway with the newer regulatory ARCND4 locus involving TWIST1/HDAC9.

Environmental risk factors

No validated environmental risk factors were identified in the retrieved evidence for ARCND. Given the congenital Mendelian etiology, environmental modifiers may exist but are not established here.

2.3 Protective factors

No protective genetic or environmental factors were identified in the retrieved evidence.

2.4 Gene–environment interactions

No gene–environment interaction evidence was identified in the retrieved materials.

3. Phenotypes

3.1 Core phenotype (triad)

The core clinical triad is consistently stated as: - Question-mark ears (QME) - Mandibular condyle hypoplasia - Micrognathia

This is explicitly stated in a 2024 clinical report: “The typical triad manifestations of ARCND include question mark ears (QMEs), mandibular condyle hypoplasia, and micrognathia.” (Shi et al., 2024; https://doi.org/10.1186/s12903-024-04575-1; Jul 2024) (shi2024novelgnai3mutation pages 1-2)

3.2 Additional phenotypes and frequencies/statistics

ARCND shows broad inter- and intra-familial variability and incomplete penetrance in some dominant families. (clouthier2013understandingthebasis pages 1-3, rieder2012ahumanhomeotic pages 3-5)

Features beyond the triad reported across sources include: microstomia/narrow mouth, prominent/full cheeks, glossoptosis, palatal anomalies (including cleft palate), facial asymmetry, pre/postauricular tags, hearing loss, feeding difficulties, respiratory distress/airway obstruction, dental crowding/malocclusion, and TMJ pathology (including ankylosis). (clouthier2013understandingthebasis pages 1-3, rieder2012ahumanhomeotic pages 1-2, tavares2017targetedmolecularinvestigation pages 4-6)

Phenotype frequencies/statistics from retrieved cohort tables and analyses: - Full cheeks and QME association: In one study, full cheeks were significantly overrepresented (P = 0.0026) and QME was strongly associated with ACS (P = 0.0001). (tavares2017targetedmolecularinvestigation pages 4-6) - Selected frequency examples summarized in a literature table include microstomia 10/11 and prominent cheeks 10/11 in one reported group, and respiratory distress 6/10 in one group (noting small denominators and missing reporting). (tavares2016identificaçãodenovas pages 67-68)

3.3 Age of onset, severity, progression

Onset: congenital / prenatal developmental.
Severity: variable, from isolated ear findings (IQME) to severe mandibular hypoplasia with airway compromise.
Progression: TMJ ankylosis can be progressive and severe cases may cause airway obstruction requiring tracheostomy (reported in earlier primary literature). (rieder2012ahumanhomeotic pages 1-2)

3.4 Quality-of-life impact

Quantitative QOL instruments were not found in retrieved evidence. However, severe dentofacial deformities are described as “present[ing] considerable challenges in patients’ lives and clinical treatment.” (shi2024novelgnai3mutation pages 1-2)

3.5 Suggested HPO terms (non-exhaustive)

Based on phenotypes described in retrieved evidence: - Question mark ear / auricular clefting: HP:0009907 (Question mark ear; commonly used HPO term for QME) - Micrognathia: HP:0000347 - Mandibular condyle hypoplasia: HP:0009119 (Mandibular condyle hypoplasia) - Microstomia: HP:0000174 - Glossoptosis: HP:0000162 - Cleft palate: HP:0000175 - Hearing impairment: HP:0000365 - Facial asymmetry: HP:0000324 - Malocclusion/crowded teeth: HP:0000689 (Crowding of teeth), HP:0000688 (Malocclusion)

(These HPO identifiers are standard ontology mappings; the evidence for the underlying phenotypes is in the cited papers.) (clouthier2013understandingthebasis pages 1-3, tavares2017targetedmolecularinvestigation pages 4-6, shi2024novelgnai3mutation pages 2-6)

4. Genetic / molecular information

4.1 Causal genes and loci

Causal genes/locus in retrieved evidence include PLCB4, GNAI3, EDN1, and a 7p duplication affecting regulatory elements interacting with TWIST1 (HDAC9/TWIST1 region). (tavares2017targetedmolecularinvestigation pages 4-6, gordon2013mutationsinendothelin pages 1-2, tavares2022newlocusunderlying pages 5-6)

4.2 Pathogenic variants: types and functional consequences

PLCB4: predominantly missense variants in catalytic domains (X/Y), with evidence suggesting dominant-negative action for many heterozygous missense alleles; additionally, biallelic loss-of-function (deletions/splice) can cause recessive disease (ARCND2B). (gordon2013heterogeneityofmutational pages 11-12, tavares2016identificaçãodenovas pages 67-68)
GNAI3: multiple variants cluster in GDP/GTP-binding motifs; multiple sources argue for a dominant-negative mechanism affecting EDN1 pathway signaling. (tavares2015novelvariantsin pages 1-2, gordon2013heterogeneityofmutational pages 11-12)
EDN1: homozygous mutations affecting processing/peptide can cause recessive ACS; other mutations can cause dominant isolated QME, consistent with mutation-dependent residual ligand activity. (gordon2013mutationsinendothelin pages 1-2)
HDAC9/TWIST1 regulatory duplication (ARCND4): a 430 kb tandem duplication with functional evidence for altered TWIST1 regulation and neural crest cell migration/osteogenesis effects in iPSC-derived models. (tavares2022newlocusunderlying pages 5-6, tavares2022newlocusunderlying pages 4-4)

4.3 Allele frequencies

Population-database frequency statements were limited in retrieved excerpts. Example: GNAI3 p.Gly40Arg was “not observed in 10,758 control chromosomes” in Rieder et al. (2012). (rieder2012ahumanhomeotic pages 3-5)

4.4 Modifier genes / epigenetics / chromosomal abnormalities

No validated modifier genes or epigenetic signatures specific to ARCND were found in retrieved evidence.

5. Environmental information

No ARCND-specific environmental, lifestyle, or infectious contributors were identified in retrieved evidence.

6. Mechanism / pathophysiology

6.1 Molecular pathway: EDN1–EDNRA–(GNAI3/PLCB4)–DLX5/6 craniofacial patterning

A central mechanistic model supported by human genetics, functional assays, and animal studies is disruption of endothelin-1 signaling in cranial neural crest: - EDN1 is a ligand critical for patterning the mandibular portion of the first pharyngeal arch via EDNRA signaling; murine deletion of Edn1/Ednra/Ece1 causes severe mandibular defects. (gordon2013mutationsinendothelin pages 1-2) - In human ACS, mutations in PLCB4 and GNAI3 are proposed to act as core intracellular effectors downstream of endothelin receptor signaling; patient-derived osteoblast assays showed significantly reduced DLX5 and DLX6 expression, consistent with impaired mandibular identity specification. (rieder2012ahumanhomeotic pages 1-2) - Clouthier et al. (2013) synthesize that loss of EDN1/EDNRA signaling causes “loss of mandibular neural crest cell identity and repatterning,” producing a homeotic shift toward maxillary-like morphology. (clouthier2013understandingthebasis pages 1-3)

6.2 Regulatory mechanism: TWIST1 dosage and neural crest migration (ARCND4)

Tavares et al. (2022) established a fourth locus involving a 430 kb tandem duplication in the HDAC9 region with regulatory contacts to TWIST1: - Capture-C revealed multiple cis interactions between the TWIST1 promoter and regulatory elements in the duplicated region. (tavares2022newlocusunderlying pages 1-1) - Patient iPSC-derived neural crest cells (iNCCs) showed HDAC9 upregulation (3.15-fold; p=0.009) and TWIST1 upregulation (2.03-fold; p=0.03), with ~4.3-fold reduced migratory capacity (p=0.0009). (tavares2022newlocusunderlying pages 5-6) - NCC-derived mesenchymal cells showed impaired osteogenic differentiation (e.g., markedly reduced ALP activity and reduced mineralization). (tavares2022newlocusunderlying pages 5-6)

6.3 Suggested GO biological process terms (examples)

Neural crest cell migration: GO:0001755
Craniofacial morphogenesis: GO:0060325
Pharyngeal arch development: GO:0060034
Endothelin receptor signaling pathway: GO:0072000 (related terms depending on curation)
Osteoblast differentiation / ossification: GO:0001649, GO:0001503

6.4 Suggested cell types (Cell Ontology; examples)

Cranial neural crest cell: CL:0002638 (commonly used for neural crest lineage)
Mesenchymal stem cell: CL:0000134
Osteoblast: CL:0000062

(Functional evidence for NCC involvement and osteogenic defects is supported by iPSC-derived NCC and nMSC assays in Tavares et al. 2022.) (tavares2022newlocusunderlying pages 5-6)

7. Anatomical structures affected

7.1 Organ/tissue level (with UBERON suggestions)

Primary structures: - External ear / pinna (UBERON:0001690) — QME malformation at helix–lobule junction. (clouthier2013understandingthebasis pages 1-3) - Mandible (UBERON:0001684) — micrognathia, mandibular hypoplasia. (clouthier2013understandingthebasis pages 1-3, shi2024novelgnai3mutation pages 2-6) - Temporomandibular joint (UBERON:0002388) — condylar hypoplasia; ankylosis in some cases. (rieder2012ahumanhomeotic pages 1-2) - First/second pharyngeal arches (UBERON:0004456, UBERON:0004457; developmental structures) (tavares2022newlocusunderlying pages 1-2)

Secondary/associated: - Upper airway/oropharynx (UBERON:0001723 pharynx; airway volumes) in severe micrognathia/OSA. (shi2024novelgnai3mutation pages 2-6)

8. Temporal development (natural history)

ARCND is a congenital developmental disorder, sometimes detectable prenatally by ultrasound when severe micrognathia/mandibular hypoplasia is present.

Prenatal case evidence: Liu et al. (2021) report prenatal ultrasound identification of severe micrognathia and mandibular hypoplasia with polyhydramnios, followed by WES identification of a de novo GNAI3 variant (p.Ser47Asn). The abstract states: “Severe micrognathia and mandibular hypoplasia accompanied by polyhydramnios are prenatal indicators of ACS.” (https://doi.org/10.1186/s12884-021-04238-x; Nov 2021) (liu2021prenataldiagnosisof pages 1-3)

9. Inheritance and population

9.1 Inheritance

ARCND can be autosomal dominant or autosomal recessive, depending on gene and variant class: - Dominant inheritance with variable expressivity and occasional non-penetrance is widely noted (e.g., GNAI3/PLCB4 families). (clouthier2013understandingthebasis pages 1-3, rieder2012ahumanhomeotic pages 3-5) - EDN1 can cause recessive ACS and dominant isolated QME. (gordon2013mutationsinendothelin pages 1-2) - ARCND2 includes dominant ARCND2A and recessive ARCND2B. (zhang2024auriculocondylarsyndrome2 pages 1-2)

9.2 Epidemiology

ARCND is repeatedly described as extremely rare: - Orphanet-cited prevalence “under 1 in 1,000,000.” (tavares2022newlocusunderlying pages 1-2) - “Fewer than 100 cases” reported is stated in a 2024 case report background. (shi2024novelgnai3mutation pages 1-2)

Robust population prevalence/incidence estimates were not provided in the retrieved primary texts.

10. Diagnostics

10.1 Clinical diagnosis

The clinical triad is emphasized as the diagnostic anchor, with recognition that incomplete presentations occur and can lead to misdiagnosis.

Direct abstract quote (2024): “ARCND is a monogenic and rare condition that can be diagnosed based on its clinical triad of core features.” (Shi et al., 2024; https://doi.org/10.1186/s12903-024-04575-1) (shi2024novelgnai3mutation pages 1-2)

10.2 Differential diagnosis

A 2024 clinical report lists potential misdiagnoses including: - Oculo-auriculo-vertebral spectrum - Treacher Collins syndrome - Mandibulofacial dysostosis - Guion-Almeida type - Meier-Gorlin syndrome

(shi2024novelgnai3mutation pages 1-2)

10.3 Genetic testing and real-world implementation

WES is repeatedly used in modern diagnosis and case resolution (including prenatal and postnatal), identifying novel GNAI3 insertions/missense changes. (shi2024novelgnai3mutation pages 1-2, liu2021prenataldiagnosisof pages 1-3)
Targeted sequencing of PLCB4, GNAI3, EDN1 is used for patients in the clinical spectrum and supports genotype–phenotype correlation work. (tavares2017targetedmolecularinvestigation pages 4-6)

In prenatal settings, WES has been used as confirmatory testing when ultrasound indicates severe mandibular anomalies. (liu2021prenataldiagnosisof pages 1-3)

10.4 Suggested diagnostic workflow (evidence-based synthesis)

1) Recognize craniofacial pattern consistent with ARCND (QME + micrognathia + condylar hypoplasia) (clouthier2013understandingthebasis pages 1-3, tavares2017targetedmolecularinvestigation pages 4-6) 2) Molecular testing: targeted ARCND genes (PLCB4, GNAI3, EDN1) or WES; consider CNV analysis if negative (HDAC9/TWIST1 duplication) (tavares2017targetedmolecularinvestigation pages 4-6, tavares2022newlocusunderlying pages 4-4) 3) Multidisciplinary craniofacial and airway evaluation in severe cases (sleep study/OSA assessment when indicated) (shi2024novelgnai3mutation pages 2-6)

11. Outcomes / prognosis

ARCND outcomes depend on severity (airway compromise, feeding difficulties, craniofacial growth, TMJ involvement). Quantitative survival data were not found in the retrieved evidence.

Functional outcome example (2024, 5-year follow-up): A patient with ARCND treated with sequential orthodontics, distraction osteogenesis, and orthognathic surgery had measurable improvements in airway and sleep-disordered breathing: airway volume increased from 18,672 mm³ to 32,880 mm³, AHI improved to 0.5 with SpO2 97%, maximal mouth opening 40 mm, and stability maintained at follow-up with return to normal life. (shi2024novelgnai3mutation pages 2-6)

12. Treatment

12.1 Current applications and real-world implementations

There are no disease-specific pharmacotherapies in the retrieved evidence; management is primarily craniofacial, orthodontic, and surgical, tailored to severity.

A detailed modern treatment implementation (Shi et al., 2024) included: - Multidisciplinary planning and 3D digital technology guidance - Preoperative orthodontic treatment with extractions and alignment - Mandibular distraction osteogenesis (bilateral distractors) - Orthognathic surgery (e.g., Le Fort I, BSSRO, genioplasty) - Demonstrated 5-year stable functional improvement (airway metrics, OSA resolution) (shi2024novelgnai3mutation pages 2-6)

12.2 MAXO (Medical Action Ontology) term suggestions

Mandibular distraction osteogenesis: MAXO:0001170 (Distraction osteogenesis; exact ID may vary by MAXO version)
Orthognathic surgery / corrective jaw surgery: MAXO:0000127 (Surgical procedure) with more specific jaw surgery subclass if available
Genetic testing / exome sequencing: MAXO:0000120 (Genetic testing)
Polysomnography / sleep study: MAXO:0000537 (Sleep study; exact ID may vary)

(These MAXO mappings are suggestions; evidence of the interventions is in the cited case report.) (shi2024novelgnai3mutation pages 2-6)

12.3 Clinical trials

ClinicalTrials.gov search in this run did not identify ARCND-specific interventional trials; retrieved trials related to orthognathic surgery or dysgnathic patients appear generic rather than syndrome-specific. (clinical trial metadata returned; no ARCND-targeted NCT found) (shi2024novelgnai3mutation pages 2-6)

13. Prevention

Primary prevention is not established because ARCND is genetic and typically congenital.

Potential prevention/mitigation strategies in practice include: - Genetic counseling and recurrence risk assessment for families with known pathogenic variants (implied by Mendelian inheritance patterns and use of prenatal molecular testing). (liu2021prenataldiagnosisof pages 1-3, gordon2013mutationsinendothelin pages 1-2) - Prenatal diagnosis when familial pathogenic variants are known or when severe mandibular anomalies are detected by ultrasound, followed by confirmatory molecular testing. (liu2021prenataldiagnosisof pages 1-3)

14. Other species / natural disease

Natural disease analogs in other species were not identified in retrieved evidence. However, mechanistic insights rely on vertebrate developmental models: - Mouse loss-of-function of Edn1/Ednra/Ece1 produces mandibular patterning defects, supporting causality of the endothelin pathway in jaw identity specification. (gordon2013mutationsinendothelin pages 1-2)

15. Model organisms

ARCND mechanisms are informed by mouse and zebrafish craniofacial development studies summarized in the 2013 Seminars review, alongside human genetics. (clouthier2013understandingthebasis pages 1-3)

A human stem-cell/iPSC model has been used as a complementary system for ARCND4, demonstrating altered gene expression and functional deficits in iPSC-derived cranial neural crest migration and osteogenic differentiation. (tavares2022newlocusunderlying pages 5-6)

Recent developments (prioritizing 2023–2024)

1) 2024: Longitudinal treatment outcomes and digital surgical workflows - BMC Oral Health (Jul 2024) reports a novel inherited GNAI3 insertion and detailed multi-stage orthodontic + surgical treatment with quantitative improvements in airway volume and sleep apnea metrics at 5 years. (https://doi.org/10.1186/s12903-024-04575-1) (shi2024novelgnai3mutation pages 2-6) - Visual evidence of phenotype and treatment planning (Figures showing micrognathia/condylar hypoplasia and digital workflow) was retrieved. (shi2024novelgnai3mutation media 1e0f905a, shi2024novelgnai3mutation media 063b200e)

2) 2024: Expanded PLCB4 variant spectrum and neonatal presentation - Molecular Genetics & Genomic Medicine (Apr 2024) reports a de novo PLCB4 variant and consolidates subtype nomenclature and prevalence statements, including ARCND subtype OMIM numbers and literature counts (36 PLCB4-mutant patients retrieved). (https://doi.org/10.1002/mgg3.2441) (zhang2024auriculocondylarsyndrome2 pages 2-5, zhang2024auriculocondylarsyndrome2 pages 1-2)

3) 2023: Continued mechanistic refinement in endothelin receptor signaling (related craniofacial endothelin disorders) - Although focused on EDNRA gain-of-function in mandibulofacial dysostosis with alopecia (MFDA), JCI 2023 provides modern GPCR allostery/ligand affinity mechanistic analysis relevant to endothelin receptor biology broadly. (https://doi.org/10.1172/jci151536; Feb 2023) (tavares2022newlocusunderlying pages 1-2)

Expert opinion / authoritative synthesis

The 2013 Seminars review (Clouthier et al.) remains an authoritative synthesis linking human genetics to mouse/zebrafish developmental biology and framing ARCND as a neural crest patterning disorder driven by loss of mandibular identity cues in EDN1/EDNRA signaling. (clouthier2013understandingthebasis pages 1-3)

A 2022 J Med Genet study provides authoritative locus-level expansion beyond the classic EDN1 pathway genes by demonstrating a regulatory duplication affecting TWIST1 control elements and measurable NCC migration defects in iPSC-derived models—supporting the view that ARCND includes both signal-transduction and regulatory/cranial neural crest migration etiologies. (tavares2022newlocusunderlying pages 5-6)

Visual evidence (phenotype and management)

Patient craniofacial phenotype and mandibular condyle hypoplasia on 3D CT reconstructions (Figure 1) and digital treatment workflow (Figure 4) from the 2024 ARCND case report. (shi2024novelgnai3mutation media 1e0f905a, shi2024novelgnai3mutation media 063b200e)

Key limitations of this report (evidence gaps)

Specific ICD-10/ICD-11 and MeSH identifiers were not present in the retrieved evidence.
Systematic, population-based epidemiology (incidence/prevalence by region) and formal QOL measures were not found in the retrieved primary texts.
ARCND-specific interventional clinical trials were not identified in the clinical trials search results during this run.

References (URLs and publication dates)

Rieder MJ et al. Am J Hum Genet. May 2012. https://doi.org/10.1016/j.ajhg.2012.04.002 (rieder2012ahumanhomeotic pages 1-2, rieder2012ahumanhomeotic pages 3-5)
Gordon CT et al. Am J Hum Genet. Dec 2013. https://doi.org/10.1016/j.ajhg.2013.10.023 (gordon2013mutationsinendothelin pages 1-2)
Clouthier DE et al. Am J Med Genet C Semin Med Genet. Nov 2013. https://doi.org/10.1002/ajmg.c.31376 (clouthier2013understandingthebasis pages 1-3)
Tavares VLR et al. Am J Med Genet A. Apr 2017. https://doi.org/10.1002/ajmg.a.38101 (tavares2017targetedmolecularinvestigation pages 4-6)
Tavares VLR et al. J Med Genet. Nov 2022. https://doi.org/10.1136/jmedgenet-2021-107825 (tavares2022newlocusunderlying pages 5-6, tavares2022newlocusunderlying pages 4-4)
Zhang Y et al. Mol Genet Genomic Med. Apr 2024. https://doi.org/10.1002/mgg3.2441 (zhang2024auriculocondylarsyndrome2 pages 2-5, zhang2024auriculocondylarsyndrome2 pages 1-2)
Shi Y et al. BMC Oral Health. Jul 2024. https://doi.org/10.1186/s12903-024-04575-1 (shi2024novelgnai3mutation pages 2-6, shi2024novelgnai3mutation media 1e0f905a)
OpenTargets disease-target mapping (MONDO mapping). (OpenTargets Search: Auriculocondylar syndrome)

References

(clouthier2013understandingthebasis pages 1-3): David E. Clouthier, Maria Rita Passos‐Bueno, Andre L.P. Tavares, Stanislas Lyonnet, Jeanne Amiel, and Christopher T. Gordon. Understanding the basis of auriculocondylar syndrome: insights from human, mouse and zebrafish genetic studies. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 163:306-317, Nov 2013. URL: https://doi.org/10.1002/ajmg.c.31376, doi:10.1002/ajmg.c.31376. This article has 69 citations.
(rieder2012ahumanhomeotic pages 1-2): Mark J. Rieder, Glenn E. Green, Sarah S. Park, Brendan D. Stamper, Christopher T. Gordon, Jason M. Johnson, Christopher M. Cunniff, Joshua D. Smith, Sarah B. Emery, Stanislas Lyonnet, Jeanne Amiel, Muriel Holder, Andrew A. Heggie, Michael J. Bamshad, Deborah A. Nickerson, Timothy C. Cox, Anne V. Hing, Jeremy A. Horst, and Michael L. Cunningham. A human homeotic transformation resulting from mutations in plcb4 and gnai3 causes auriculocondylar syndrome. American journal of human genetics, 90 5:907-14, May 2012. URL: https://doi.org/10.1016/j.ajhg.2012.04.002, doi:10.1016/j.ajhg.2012.04.002. This article has 114 citations and is from a highest quality peer-reviewed journal.
(shi2024novelgnai3mutation pages 2-6): Yulin Shi, Liang Rong, Siying Liu, Yiwen Liu, Chunlin Zong, Jinbiao Lu, Hongtao Shang, Yang Xue, and Lei Tian. Novel gnai3 mutation in a chinese family with auriculocondylar syndrome and treatment of severe dentofacial deformities: a 5-year follow-up case report. BMC Oral Health, Jul 2024. URL: https://doi.org/10.1186/s12903-024-04575-1, doi:10.1186/s12903-024-04575-1. This article has 2 citations and is from a peer-reviewed journal.
(gordon2013heterogeneityofmutational pages 1-2): Christopher T Gordon, Alice Vuillot, Sandrine Marlin, Erica Gerkes, Alex Henderson, Adila AlKindy, Muriel Holder-Espinasse, Sarah S Park, Asma Omarjee, Mateo Sanchis-Borja, Eya Ben Bdira, Myriam Oufadem, Birgit Sikkema-Raddatz, Alison Stewart, Rodger Palmer, Ruth McGowan, Florence Petit, Bruno Delobel, Michael R Speicher, Paul Aurora, David Kilner, Philippe Pellerin, Marie Simon, Jean-Paul Bonnefont, Edward S Tobias, Sixto García-Miñaúr, Maria Bitner-Glindzicz, Pernille Lindholm, Brigitte A Meijer, Véronique Abadie, Françoise Denoyelle, Marie-Paule Vazquez, Christa Rotky-Fast, Vincent Couloigner, Sébastien Pierrot, Yves Manach, Sylvain Breton, Yvonne M C Hendriks, Arnold Munnich, Linda Jakobsen, Peter Kroisel, Angela Lin, Leonard B Kaban, Lina Basel-Vanagaite, Louise Wilson, Michael L Cunningham, Stanislas Lyonnet, and Jeanne Amiel. Heterogeneity of mutational mechanisms and modes of inheritance in auriculocondylar syndrome. Journal of Medical Genetics, 50:174-186, Jan 2013. URL: https://doi.org/10.1136/jmedgenet-2012-101331, doi:10.1136/jmedgenet-2012-101331. This article has 58 citations and is from a domain leading peer-reviewed journal.
(OpenTargets Search: Auriculocondylar syndrome): Open Targets Query (Auriculocondylar syndrome, 6 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.
(tavares2022newlocusunderlying pages 1-2): Vanessa Luiza Romanelli Tavares, Sofia Ligia Guimarães-Ramos, Yan Zhou, Cibele Masotti, Suzana Ezquina, Danielle de Paula Moreira, Henk Buermans, Renato S Freitas, Johan T Den Dunnen, Stephen R F Twigg, and Maria Rita Passos-Bueno. New locus underlying auriculocondylar syndrome (arcnd): 430 kb duplication involving twist1 regulatory elements. Journal of Medical Genetics, 59:895-905, Nov 2022. URL: https://doi.org/10.1136/jmedgenet-2021-107825, doi:10.1136/jmedgenet-2021-107825. This article has 9 citations and is from a domain leading peer-reviewed journal.
(shi2024novelgnai3mutation pages 1-2): Yulin Shi, Liang Rong, Siying Liu, Yiwen Liu, Chunlin Zong, Jinbiao Lu, Hongtao Shang, Yang Xue, and Lei Tian. Novel gnai3 mutation in a chinese family with auriculocondylar syndrome and treatment of severe dentofacial deformities: a 5-year follow-up case report. BMC Oral Health, Jul 2024. URL: https://doi.org/10.1186/s12903-024-04575-1, doi:10.1186/s12903-024-04575-1. This article has 2 citations and is from a peer-reviewed journal.
(zhang2024auriculocondylarsyndrome2 pages 1-2): Yongli Zhang, Yuwei Zhao, Liying Dai, Yu Liu, and Zifeng Shi. Auriculocondylar syndrome 2 caused by a novel plcb4 variant in a male chinese neonate: a case report and review of the literature. Molecular Genetics & Genomic Medicine, Apr 2024. URL: https://doi.org/10.1002/mgg3.2441, doi:10.1002/mgg3.2441. This article has 3 citations and is from a peer-reviewed journal.
(gordon2013mutationsinendothelin pages 1-2): Christopher T. Gordon, Florence Petit, Peter M. Kroisel, Linda Jakobsen, Roseli Maria Zechi-Ceide, Myriam Oufadem, Christine Bole-Feysot, Solenn Pruvost, Cécile Masson, Frédéric Tores, Thierry Hieu, Patrick Nitschké, Pernille Lindholm, Philippe Pellerin, Maria Leine Guion-Almeida, Nancy Mizue Kokitsu-Nakata, Siulan Vendramini-Pittoli, Arnold Munnich, Stanislas Lyonnet, Muriel Holder-Espinasse, and Jeanne Amiel. Mutations in endothelin 1 cause recessive auriculocondylar syndrome and dominant isolated question-mark ears. American journal of human genetics, 93 6:1118-25, Dec 2013. URL: https://doi.org/10.1016/j.ajhg.2013.10.023, doi:10.1016/j.ajhg.2013.10.023. This article has 86 citations and is from a highest quality peer-reviewed journal.
(tavares2017targetedmolecularinvestigation pages 4-6): Vanessa L. Romanelli Tavares, Roseli M. Zechi‐Ceide, Debora R. Bertola, Christopher T. Gordon, Simone G. Ferreira, Gabriella S. P. Hsia, Guilherme L. Yamamoto, Suzana A. M. Ezquina, Nancy M. Kokitsu‐Nakata, Siulan Vendramini‐Pittoli, Renato S. Freitas, Josiane Souza, Cesar A. Raposo‐Amaral, Mayana Zatz, Jeanne Amiel, Maria L. Guion‐Almeida, and Maria Rita Passos‐Bueno. Targeted molecular investigation in patients within the clinical spectrum of auriculocondylar syndrome. American Journal of Medical Genetics Part A, 173:938-945, Apr 2017. URL: https://doi.org/10.1002/ajmg.a.38101, doi:10.1002/ajmg.a.38101. This article has 17 citations.
(tavares2022newlocusunderlying pages 5-6): Vanessa Luiza Romanelli Tavares, Sofia Ligia Guimarães-Ramos, Yan Zhou, Cibele Masotti, Suzana Ezquina, Danielle de Paula Moreira, Henk Buermans, Renato S Freitas, Johan T Den Dunnen, Stephen R F Twigg, and Maria Rita Passos-Bueno. New locus underlying auriculocondylar syndrome (arcnd): 430 kb duplication involving twist1 regulatory elements. Journal of Medical Genetics, 59:895-905, Nov 2022. URL: https://doi.org/10.1136/jmedgenet-2021-107825, doi:10.1136/jmedgenet-2021-107825. This article has 9 citations and is from a domain leading peer-reviewed journal.
(tavares2015novelvariantsin pages 1-2): Vanessa L Romanelli Tavares, Christopher T Gordon, Roseli M Zechi-Ceide, Nancy Mizue Kokitsu-Nakata, Norine Voisin, Tiong Y Tan, Andrew A Heggie, Siulan Vendramini-Pittoli, Evan J Propst, Blake C Papsin, Tatiana T Torres, Henk Buermans, Luciane Portas Capelo, Johan T den Dunnen, Maria L Guion-Almeida, Stanislas Lyonnet, Jeanne Amiel, and Maria Rita Passos-Bueno. Novel variants in gnai3 associated with auriculocondylar syndrome strengthen a common dominant negative effect. European Journal of Human Genetics, 23:481-485, Jul 2015. URL: https://doi.org/10.1038/ejhg.2014.132, doi:10.1038/ejhg.2014.132. This article has 36 citations and is from a domain leading peer-reviewed journal.
(tavares2022newlocusunderlying pages 4-4): Vanessa Luiza Romanelli Tavares, Sofia Ligia Guimarães-Ramos, Yan Zhou, Cibele Masotti, Suzana Ezquina, Danielle de Paula Moreira, Henk Buermans, Renato S Freitas, Johan T Den Dunnen, Stephen R F Twigg, and Maria Rita Passos-Bueno. New locus underlying auriculocondylar syndrome (arcnd): 430 kb duplication involving twist1 regulatory elements. Journal of Medical Genetics, 59:895-905, Nov 2022. URL: https://doi.org/10.1136/jmedgenet-2021-107825, doi:10.1136/jmedgenet-2021-107825. This article has 9 citations and is from a domain leading peer-reviewed journal.
(rieder2012ahumanhomeotic pages 3-5): Mark J. Rieder, Glenn E. Green, Sarah S. Park, Brendan D. Stamper, Christopher T. Gordon, Jason M. Johnson, Christopher M. Cunniff, Joshua D. Smith, Sarah B. Emery, Stanislas Lyonnet, Jeanne Amiel, Muriel Holder, Andrew A. Heggie, Michael J. Bamshad, Deborah A. Nickerson, Timothy C. Cox, Anne V. Hing, Jeremy A. Horst, and Michael L. Cunningham. A human homeotic transformation resulting from mutations in plcb4 and gnai3 causes auriculocondylar syndrome. American journal of human genetics, 90 5:907-14, May 2012. URL: https://doi.org/10.1016/j.ajhg.2012.04.002, doi:10.1016/j.ajhg.2012.04.002. This article has 114 citations and is from a highest quality peer-reviewed journal.
(tavares2016identificaçãodenovas pages 67-68): Vanessa Luiza Romanelli Tavares. Identificação de novas variantes causativas e investigação da heterogeneidade clínica da síndrome aurículo-condilar identification of novel causative variants and investigation of clinical heterogeneity of auriculocondylar syndrome. ArXiv, Mar 2016. URL: https://doi.org/10.11606/t.41.2016.tde-14072016-142513, doi:10.11606/t.41.2016.tde-14072016-142513. This article has 0 citations.
(liu2021prenataldiagnosisof pages 1-3): Xiaoliang Liu, Wei Sun, Jun Wang, Guoming Chu, Rong He, Bijun Zhang, and Yanyan Zhao. Prenatal diagnosis of auriculocondylar syndrome with a novel missense variant of gnai3: a case report. BMC Pregnancy and Childbirth, Nov 2021. URL: https://doi.org/10.1186/s12884-021-04238-x, doi:10.1186/s12884-021-04238-x. This article has 8 citations and is from a peer-reviewed journal.
(gordon2013heterogeneityofmutational pages 11-12): Christopher T Gordon, Alice Vuillot, Sandrine Marlin, Erica Gerkes, Alex Henderson, Adila AlKindy, Muriel Holder-Espinasse, Sarah S Park, Asma Omarjee, Mateo Sanchis-Borja, Eya Ben Bdira, Myriam Oufadem, Birgit Sikkema-Raddatz, Alison Stewart, Rodger Palmer, Ruth McGowan, Florence Petit, Bruno Delobel, Michael R Speicher, Paul Aurora, David Kilner, Philippe Pellerin, Marie Simon, Jean-Paul Bonnefont, Edward S Tobias, Sixto García-Miñaúr, Maria Bitner-Glindzicz, Pernille Lindholm, Brigitte A Meijer, Véronique Abadie, Françoise Denoyelle, Marie-Paule Vazquez, Christa Rotky-Fast, Vincent Couloigner, Sébastien Pierrot, Yves Manach, Sylvain Breton, Yvonne M C Hendriks, Arnold Munnich, Linda Jakobsen, Peter Kroisel, Angela Lin, Leonard B Kaban, Lina Basel-Vanagaite, Louise Wilson, Michael L Cunningham, Stanislas Lyonnet, and Jeanne Amiel. Heterogeneity of mutational mechanisms and modes of inheritance in auriculocondylar syndrome. Journal of Medical Genetics, 50:174-186, Jan 2013. URL: https://doi.org/10.1136/jmedgenet-2012-101331, doi:10.1136/jmedgenet-2012-101331. This article has 58 citations and is from a domain leading peer-reviewed journal.
(zhang2024auriculocondylarsyndrome2 pages 2-5): Yongli Zhang, Yuwei Zhao, Liying Dai, Yu Liu, and Zifeng Shi. Auriculocondylar syndrome 2 caused by a novel plcb4 variant in a male chinese neonate: a case report and review of the literature. Molecular Genetics & Genomic Medicine, Apr 2024. URL: https://doi.org/10.1002/mgg3.2441, doi:10.1002/mgg3.2441. This article has 3 citations and is from a peer-reviewed journal.
(tavares2016identificaçãodenovas pages 68-72): Vanessa Luiza Romanelli Tavares. Identificação de novas variantes causativas e investigação da heterogeneidade clínica da síndrome aurículo-condilar identification of novel causative variants and investigation of clinical heterogeneity of auriculocondylar syndrome. ArXiv, Mar 2016. URL: https://doi.org/10.11606/t.41.2016.tde-14072016-142513, doi:10.11606/t.41.2016.tde-14072016-142513. This article has 0 citations.
(tavares2022newlocusunderlying pages 1-1): Vanessa Luiza Romanelli Tavares, Sofia Ligia Guimarães-Ramos, Yan Zhou, Cibele Masotti, Suzana Ezquina, Danielle de Paula Moreira, Henk Buermans, Renato S Freitas, Johan T Den Dunnen, Stephen R F Twigg, and Maria Rita Passos-Bueno. New locus underlying auriculocondylar syndrome (arcnd): 430 kb duplication involving twist1 regulatory elements. Journal of Medical Genetics, 59:895-905, Nov 2022. URL: https://doi.org/10.1136/jmedgenet-2021-107825, doi:10.1136/jmedgenet-2021-107825. This article has 9 citations and is from a domain leading peer-reviewed journal.
(tavares2022newlocusunderlying pages 6-7): Vanessa Luiza Romanelli Tavares, Sofia Ligia Guimarães-Ramos, Yan Zhou, Cibele Masotti, Suzana Ezquina, Danielle de Paula Moreira, Henk Buermans, Renato S Freitas, Johan T Den Dunnen, Stephen R F Twigg, and Maria Rita Passos-Bueno. New locus underlying auriculocondylar syndrome (arcnd): 430 kb duplication involving twist1 regulatory elements. Journal of Medical Genetics, 59:895-905, Nov 2022. URL: https://doi.org/10.1136/jmedgenet-2021-107825, doi:10.1136/jmedgenet-2021-107825. This article has 9 citations and is from a domain leading peer-reviewed journal.
(shi2024novelgnai3mutation media 1e0f905a): Yulin Shi, Liang Rong, Siying Liu, Yiwen Liu, Chunlin Zong, Jinbiao Lu, Hongtao Shang, Yang Xue, and Lei Tian. Novel gnai3 mutation in a chinese family with auriculocondylar syndrome and treatment of severe dentofacial deformities: a 5-year follow-up case report. BMC Oral Health, Jul 2024. URL: https://doi.org/10.1186/s12903-024-04575-1, doi:10.1186/s12903-024-04575-1. This article has 2 citations and is from a peer-reviewed journal.
(shi2024novelgnai3mutation media 063b200e): Yulin Shi, Liang Rong, Siying Liu, Yiwen Liu, Chunlin Zong, Jinbiao Lu, Hongtao Shang, Yang Xue, and Lei Tian. Novel gnai3 mutation in a chinese family with auriculocondylar syndrome and treatment of severe dentofacial deformities: a 5-year follow-up case report. BMC Oral Health, Jul 2024. URL: https://doi.org/10.1186/s12903-024-04575-1, doi:10.1186/s12903-024-04575-1. This article has 2 citations and is from a peer-reviewed journal.

Ask OpenScientist

OpenScientist Report

Inheritance

Subtypes

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Treatments

Differential Diagnoses

Source YAML

References & Deep Research

Deep Research

Disease Characteristics Research Template

Target Disease

Research Objectives

1. Disease Information

2. Etiology

3. Phenotypes

4. Genetic/Molecular Information

5. Environmental Information

6. Mechanism / Pathophysiology

7. Anatomical Structures Affected

8. Temporal Development

9. Inheritance and Population

10. Diagnostics

11. Outcome/Prognosis

12. Treatment

13. Prevention

14. Other Species / Natural Disease

15. Model Organisms

Citation Requirements

Output Format

Auriculocondylar Syndrome (ARCND/ACS): Comprehensive Disease Characteristics Report

Executive summary

1. Disease information

1.1 Definition and current understanding

1.2 Key identifiers (available in retrieved evidence)

1.3 Synonyms and alternative names

1.4 Evidence sources (individual vs aggregated)

2. Etiology

2.1 Disease causal factors (primary causes)

2.2 Risk factors

Genetic risk factors (causal variants)

Environmental risk factors

2.3 Protective factors

2.4 Gene–environment interactions

3. Phenotypes

3.1 Core phenotype (triad)

3.2 Additional phenotypes and frequencies/statistics

3.3 Age of onset, severity, progression

3.4 Quality-of-life impact

3.5 Suggested HPO terms (non-exhaustive)

4. Genetic / molecular information

4.1 Causal genes and loci

4.2 Pathogenic variants: types and functional consequences

4.3 Allele frequencies

4.4 Modifier genes / epigenetics / chromosomal abnormalities

5. Environmental information

6. Mechanism / pathophysiology

6.1 Molecular pathway: EDN1–EDNRA–(GNAI3/PLCB4)–DLX5/6 craniofacial patterning

6.2 Regulatory mechanism: TWIST1 dosage and neural crest migration (ARCND4)

6.3 Suggested GO biological process terms (examples)

6.4 Suggested cell types (Cell Ontology; examples)

7. Anatomical structures affected

7.1 Organ/tissue level (with UBERON suggestions)

8. Temporal development (natural history)

9. Inheritance and population

9.1 Inheritance

9.2 Epidemiology

10. Diagnostics

10.1 Clinical diagnosis

10.2 Differential diagnosis

10.3 Genetic testing and real-world implementation

10.4 Suggested diagnostic workflow (evidence-based synthesis)

11. Outcomes / prognosis

12. Treatment

12.1 Current applications and real-world implementations

12.2 MAXO (Medical Action Ontology) term suggestions

12.3 Clinical trials